Cardiodefibrillation

CARDIOVERSION

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Operations: NOMESCO codes — ^TFP20 1 out of 7 registries used, show all original rules.	16269
4. Check minimum number of events None	16269
5. Include endpoints None	16269
6. Filter based on genotype QC (FinnGen only)	15895

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	CARDIOVERSION
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM	^TFP20
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Cardiodefibrillation based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	15895	5479	10416
Unadjusted period prevalence (%)	3.80	1.94	4.77
Median age at first event (years)	66.57	69.22	65.19

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
16269: Matched controls
162294

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R06.0

ICD-10 Finland

Dyspnoea

2.0

323.0

5283

31858

C09AA05

ATC

ramipril; oral

1.9

322.0

5679

35123

Z3231

NOMESCO Finland

Registered nurse

2.0

320.3

5263

31770

FKB10

NOMESCO Finland

Annuloplasty of mitral valve for insufficiency using ring

9.1

319.6

394

441

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

4.3

317.4

842

2012

B01AB05

ATC

enoxaparin; parenteral

1.9

316.3

6196

39618

TFP34

NOMESCO Finland

Electrophysiological investigation

22.7

307.7

2498

1287

I48.2

ICD-10 Finland

Chronic atrial fibrillation

8.5

307.7

2660

3642

K05

ICPC

Irregular heartbeat other

4.6

307.7

1043

2395

201

Kela drug reimbursment

Chronic cardiac insufficiency

4.2

307.7

1923

4992

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

11.1

307.7

5619

7384

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

4.8

307.7

769

1661

B01AE07

ATC

dabigatran etexilate; oral

7.0

307.7

2031

3222

I48.4

ICD-10 Finland

Atypical atrial flutter

16.5

307.7

387

240

AR6

Catheter ablation of arrhythmia, target: atrial fibrillation

59.4

307.7

463

WX892

NOMESCO Finland

Monitored bed care

2.9

307.7

2058

7644

XF404

NOMESCO Finland

Ambulatory ECG

5.6

307.7

3748

8265

342

Kela drug reimbursment

Dronedarone

37.9

307.7

727

200

I48.3

ICD-10 Finland

Typical atrial flutter

14.0

307.7

696

516

FM1BE

NOMESCO Finland

Cardiac ultrasound examination through oesophagus

6.7

307.7

3263

5832

FXA00

NOMESCO Finland

Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure

3.8

307.7

1335

3738

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.1

307.7

3994

21351

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

13.9

307.7

10665

19490

I50

ICD-10 Finland

Heart failure

4.1

307.7

1088

2769

C01BC04

ATC

flecainide; systemic

22.5

307.7

3235

1768

TFP47

NOMESCO Finland

Ablation or modification of the AV-node

24.0

307.7

402

171

I49.5

ICD-10 Finland

Sick sinus syndrome

4.8

307.7

1542

3433

AN1

Coronary angiography

2.4

307.7

3105

14539

WX404

NOMESCO Finland

Intravenous generell anesthesy

5.6

307.7

6449

16992

FPE20

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes

3.7

307.7

1435

4176

ZXD05

NOMESCO Finland

Urgent procedure

2.3

307.7

6145

33333

I48

ICD-10 Finland

Atrial fibrillation and flutter

64.7

307.7

15083

26675

WX402

NOMESCO Finland

General anaesthesia

2.5

307.7

4288

20241

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

307.7

10800

64226

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

5.0

307.7

2170

4893

XF402

NOMESCO Finland

ECG with work load test

2.6

307.7

2799

11930

B01AF03

ATC

edoxaban; oral

4.7

307.7

814

1814

AR5

Catheter ablation of arrhythmia, target: atrial flutter

27.8

307.7

277

101

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

2.7

307.7

6501

32105

I50.1

ICD-10 Finland

Left ventricular failure

4.1

307.7

1797

4812

C07AB07

ATC

bisoprolol; oral

11.6

307.7

14575

69157

I36.1

ICD-10 Finland

Nonrheumatic tricuspid (valve) insufficiency

6.8

307.7

572

866

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

3.6

307.7

3004

9660

I34.09

ICD-10 Finland

Mitral (valve) insufficiency

5.2

307.7

1654

3453

K04

ICPC

Palpitations/awareness of heart

3.7

307.7

1274

3641

I47.2

ICD-10 Finland

Ventricular tachycardia

5.4

307.7

795

1516

I50.9

ICD-10 Finland

Heart failure, unspecified

4.1

307.7

5379

17412

C07AA07

ATC

sotalol; systemic

7.0

307.7

1902

2999

I34.1

ICD-10 Finland

Mitral (valve) prolapse

5.1

307.7

967

1972

TFP44

NOMESCO Finland

Ablation treatment of typical atrial flutter

39.3

307.7

908

244

C03DA01

ATC

spironolactone; oral

3.4

307.7

3843

13502

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

4.3

307.7

6575

22244

C08DA01

ATC

verapamil; systemic

4.2

307.7

1239

3094

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

5.0

307.7

2916

6816

TFP20

NOMESCO Finland

Cardiodefibrillation

+∞

307.7

16269

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

11.4

307.7

9393

17395

C07AB02

ATC

metoprolol; systemic

2.2

307.7

4694

25240

TFP30

NOMESCO Finland

Cathetric examination for cardiac arrythmia

9.7

307.7

455

480

XF400

NOMESCO Finland

ECG with 12 standard connections

3.3

307.7

4616

17530

I35.1

ICD-10 Finland

Aortic (valve) insufficiency

3.2

307.7

1577

5250

207

Kela drug reimbursment

Chronic arrhythmias

17.0

307.7

10987

17668

I50.0

ICD-10 Finland

Congestive heart failure

4.0

307.7

2802

8098

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

307.7

3690

17770

K80

ICPC

Cardiac arrhythmia NOS

4.5

307.7

2716

6970

I47.1

ICD-10 Finland

Supraventricular tachycardia

4.3

307.7

1231

3055

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.8

307.7

2649

10569

B01AF01

ATC

rivaroxaban; oral

3.8

307.7

4429

14558

C01BD07

ATC

dronedarone; oral

35.1

307.7

591

174

I42.0

ICD-10 Finland

Dilated cardiomyopathy

4.7

307.7

990

2185

C03CA01

ATC

furosemide; systemic

3.4

307.7

8938

42534

B01AF02

ATC

apixaban; oral

6.1

307.7

6171

14731

ZXE00

NOMESCO Finland

One hour or less

2.4

307.7

7585

43677

I34.00

ICD-10 Finland

Mitral (valve) incompetence NOS or of specified cause, except rheumatic

5.9

307.7

788

1387

AQ1

Conventional electrophysiological examination

13.0

307.7

621

494

C01BD01

ATC

amiodarone; systemic

23.5

307.7

2941

1510

TFC00

NOMESCO Finland

Catheterisation of right atrium or ventricle

9.2

307.7

762

861

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

4.2

307.7

7761

28907

WX902

NOMESCO Finland

External defibrillation of heart

40.6

307.7

347

TFC25

NOMESCO Finland

Transseptal catheterisation of left atrium or ventricle

38.1

307.7

1265

358

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

8.5

307.7

4570

7129

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

5.3

307.7

1831

3781

C01AA05

ATC

digoxin; systemic

9.4

307.7

4914

7172

TFP35

NOMESCO Finland

Electroanatomical mapping

28.9

307.7

1238

462

K78

ICPC

Atrial fibrillation/flutter

9.7

307.7

5186

7454

I48.1

ICD-10 Finland

Persistent atrial fibrillation

9.6

307.7

2716

3323

Z2221

NOMESCO Finland

Medical doctor

2.1

307.7

4921

28325

AQ2

Electrophysiological electroanatomical examination

41.0

307.7

401

100

TFP46

NOMESCO Finland

Ablation treatment of atrial fibrillation

58.3

307.7

1794

344

B01AA03

ATC

warfarin; systemic

9.8

307.7

10100

23207

TPH04

NOMESCO Finland

Cathetrisation of vein

2.6

307.7

5265

24878

TFP45

NOMESCO Finland

Ablation treatment of non-typical atrial flutter

90.1

306.6

161

TFP32

NOMESCO Finland

Cathetric treatmen of cardiac arrythmia

11.5

302.8

316

280

FP4B5

NOMESCO Finland

ECG, prolonged recording (24 h)

6.0

301.9

543

927

ZXD10

NOMESCO Finland

Scheduled procedure

1.8

296.4

6735

44889

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.9

295.0

5505

34465

PH3AC

NOMESCO Finland

Flebography of internal organs with X-ray

55.4

291.5

165

PH1AC

NOMESCO Finland

Flebography of over extremity with X-ray

5.7

274.6

520

932

I71.2

ICD-10 Finland

Thoracic aortic aneurysm, without mention of rupture

3.5

268.2

966

2860

289

Kela drug reimbursment

Combination product containing sacubitril and valsartan

6.7

267.9

430

654

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

266.6

6966

47967

C09DX04

ATC

valsartan and sacubitril; oral

6.8

261.4

417

630

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.8

257.5

5271

33661

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

251.7

6312

42745

TFB00

NOMESCO Finland

Cathetrisation of pulmonal artery

4.7

251.4

598

1308

381

Kela drug reimbursment

Combination product containing sacubitril and valsartan

6.9

243.4

381

564

4273A

ICD-9 Finland

Cardiac dysrhythmias, Atrial fibrillation and flutter

4.7

240.0

574

1261

GD1LA

NOMESCO Finland

5.0

239.9

529

1086

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

238.1

2791

14733

I42.9

ICD-10 Finland

Cardiomyopathy, unspecified

5.0

231.9

508

1037

SPAT1097

SPAT

Recording of ECG

2.0

231.6

3134

17402

R04.0

ICD-10 Finland

Epistaxis

2.4

223.8

1782

8039

XF600

NOMESCO Finland

Bloodpressure measurement

2.6

223.6

1405

5680

C08DB01

ATC

diltiazem; oral

2.7

222.6

1312

5138

M04AA01

ATC

allopurinol; systemic

1.9

216.7

3103

17522

XFE00

NOMESCO Finland

Epicardial ultrasonography

3.8

208.6

665

1810

K84

ICPC

Heart disease other

3.4

208.0

802

2473

WX872

NOMESCO Finland

Intensive care

2.6

202.9

1301

5303

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.2

202.6

839

2702

FM1CD

NOMESCO Finland

Very extensive CT of heart

15.1

201.7

178

119

K77

ICPC

Heart failure

3.6

193.1

658

1873

C01BA03

ATC

disopyramide; systemic

7.8

187.8

261

338

FPE30

NOMESCO Finland

Replacement of transvenous cardiac pacemaker pulse generator

4.6

185.7

447

986

M10.9

ICD-10 Finland

Gout, unspecified

2.2

183.7

1713

8223

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

182.2

11360

94404

R4110

NOMESCO Finland

Physiotherapy

1.7

180.5

4742

31835

AS4

Physiological pacemaker insertion DDD (R)

4.5

180.2

444

998

R02

ICPC

Shortness of breath/dyspnoea

2.0

179.9

2450

13519

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

175.2

5130

35366

Angiography of the heart and coronary arteries

2.2

175.1

1540

7212

AC4

MVP

9.5

172.7

205

218

E05.89

ICD-10 Finland

Other thyrotoxicosis

13.8

172.5

160

117

FM1DG

NOMESCO Finland

Very extensive MRI examination of heart with high intesity magnet

5.4

171.9

344

648

FPD00

NOMESCO Finland

Maze procedure for atrial fibrillation

39.0

171.5

105

K99

ICPC

Cardiovascular disease other

3.1

165.4

725

2411

G47.3

ICD-10 Finland

Sleep apnoea

1.7

164.0

3953

25820

C07AB03

ATC

atenolol; systemic

2.3

161.7

1312

5932

H03BB01

ATC

carbimazole; oral

3.1

159.8

717

2416

250, ,

Kela drug reimbursment

4.2

158.6

437

1070

N02BE01

ATC

paracetamol; systemic, rectal

1.9

157.2

14331

128689

FJA10

NOMESCO Finland

Transvenous biopsy of right ventricle

9.8

155.5

180

185

FMD10

NOMESCO Finland

Replacement of aortic valve using biological prosthesis

4.0

154.8

452

1155

XF640, ,

NOMESCO Finland

3.0

153.7

696

2357

I34.9

ICD-10 Finland

Nonrheumatic mitral valve disorder, unspecified

6.3

151.7

258

416

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.5

150.3

1032

4328

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

2.3

150.2

1224

5539

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

2.4

149.5

1057

4492

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.7

149.0

840

3201

K83

ICPC

Heart valve disease NOS

4.7

148.3

344

736

WVA40

NOMESCO Finland

Initiation and monitoring of intravenous hydration

4.3

147.1

388

919

C01BC03

ATC

propafenone; systemic

11.0

144.3

154

141

FPD10

NOMESCO Finland

Surgical ablation of atrial fibrillation

21.5

143.6

107

FKC50

NOMESCO Finland

Repair of mitral valve for insufficiency using prosthetic chord

8.7

143.5

182

211

C01DA14

ATC

isosorbide mononitrate; oral

1.7

143.2

3363

21701

WX002

NOMESCO Finland

Sedation and analgesia

1.7

142.9

3447

22399

C01BA01

ATC

quinidine; oral

6.7

142.1

225

337

A02BC02

ATC

pantoprazole; systemic

1.6

140.9

10965

92690

I34.01

ICD-10 Finland

Mitral (valve) regurgitation NOS or of specified cause, except rheumatic

7.0

140.2

214

308

E05.9

ICD-10 Finland

Thyrotoxicosis, unspecified

3.5

138.8

496

1454

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

138.3

6931

53300

FFM10

NOMESCO Finland

Occlusion or excision of atrial appendage externally with a closing device

9.9

138.0

158

160

I49.3

ICD-10 Finland

Ventricular premature depolarization

2.1

137.4

1352

6596

I35.0

ICD-10 Finland

Aortic (valve) stenosis

2.1

137.3

1417

7041

H02AB06

ATC

prednisolone; systemic

1.5

137.1

7668

60292

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

135.0

4909

35160

K60

ICPC

Cardiovascular, Result test/procedure

5.6

132.6

255

463

XF655

NOMESCO Finland

Measurement of heart muscle perfusion with exercise

2.8

131.8

701

2590

I49.0

ICD-10 Finland

Ventricular fibrillation and flutter

4.9

131.8

293

605

J01CA04

ATC

amoxicillin; systemic

1.6

131.2

12075

104947

J01DB01

ATC

cefalexin; oral

1.6

129.9

12852

113436

TPH07

NOMESCO Finland

Cathetrisation of artery

1.8

129.6

2221

13076

Electrophysiological Special Examination

6.4

129.2

215

339

FPG96

NOMESCO Finland

Other implantation of permanent cardioverter-defibrillator

8.1

128.5

172

213

ZX120

NOMESCO Finland

Intravenous

1.9

126.4

1660

8977

A46

ICD-10 Finland

Erysipelas

1.7

125.1

2799

17753

I71.9

ICD-10 Finland

Aortic aneurysm of unspecified site, without mention of rupture

3.7

123.5

402

1108

FPB10

NOMESCO Finland

Cryoablation of ectopic heart focus

38.1

123.3

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

1.9

122.1

1784

9986

I42.2

ICD-10 Finland

Other hypertrophic cardiomyopathy

5.3

121.9

245

463

R00.2

ICD-10 Finland

Palpitations

2.2

121.7

1099

5175

FPD96

NOMESCO Finland

Other operation for atrial fibrillation

18.4

121.5

FKD00

NOMESCO Finland

Replacement of mitral valve using mechanical prosthesis

13.5

121.5

114

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.6

120.2

3814

26350

SPAT1104

SPAT

Monitoring of emergency patient

2.1

120.1

1248

6206

Catheter ablation of arrhythmia

7.2

119.7

177

246

K29

ICPC

Cardiovascular sympt/complt other

2.3

119.6

960

4305

ARB

Catheter ablation of arrhythmia: Cutiing or modification of the AV node

25.2

118.5

FQA10

NOMESCO Finland

Orthotopic transplantation of heart with bicaval anastomosis

34.2

118.1

I34.0

ICD-10 Finland

Mitral (valve) insufficiency

3.7

117.7

378

1032

205

Kela drug reimbursment

Chronic hypertension

1.5

115.1

5267

39321

I49.1

ICD-10 Finland

Atrial premature depolarization

2.6

114.0

714

2861

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

112.8

5928

45446

SPAT1263

SPAT

Sampling

1.5

112.8

6423

50019

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.1

112.7

1227

6202

FGC10

NOMESCO Finland

Annuloplasty of tricuspid valve using prosthetic ring

9.5

112.0

132

139

FKC20

NOMESCO Finland

Plastic repair of mitral valve leaflet for insufficiency

11.3

111.8

117

104

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

111.7

2066

12400

I42.1

ICD-10 Finland

Obstructive hypertrophic cardiomyopathy

6.9

111.3

171

248

FPG32

NOMESCO Finland

Implantation of cardioverter-defibrillator with atrial and ventricular electrodes

5.4

110.6

218

405

FKD10

NOMESCO Finland

Replacement of mitral valve using biological prosthesis

7.2

110.5

164

229

Z3226

NOMESCO Finland

Physiotherapist

1.6

110.2

2896

19072

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

109.9

1321

6915

Z50.0

ICD-10 Finland

Cardiac rehabilitation

3.8

109.1

339

905

TFP43

NOMESCO Finland

Ablation treatment for atrial tachycardia

23.7

108.8

Z71.8

ICD-10 Finland

Other specified counselling

1.5

108.0

4203

30256

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

2.8

107.6

548

1977

K79

ICPC

Paroxysmal tachycardia

6.5

107.1

176

274

AA1AD

NOMESCO Finland

CT of head and brain

1.5

107.0

4895

36417

TFP40

NOMESCO Finland

Ablation treatment for a-v node re-entry activation

5.4

106.3

212

398

WX4

NOMESCO Finland

General anaesthesias

21.1

103.9

I35.2

ICD-10 Finland

Aortic (valve) stenosis with insufficiency

2.6

102.5

615

2412

AP2

Catheterization of the right side of the heart

7.9

102.3

140

178

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

102.1

4485

33031

E66.01

ICD-10 Finland

Obesity due to excess calories

2.1

101.7

1039

5123

Z95.1

ICD-10 Finland

Presence of aortocoronary bypass graft

2.1

101.6

993

4815

K22

ICPC

Risk factor cardiovascular disease

2.0

101.3

1131

5762

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

101.3

4116

29825

42792

ICD-8 Finland

Symptomatic heart disease, Fibrillatio auricularis

4.8

100.5

228

479

1CX08, ,

NOMESCO Finland

6.6

99.8

161

246

AP3

Catheterization of the right and left side of the heart

8.5

99.5

128

151

C08CA01

ATC

amlodipine; oral

1.4

98.0

6960

55978

A12BA01

ATC

potassium chloride; oral

2.2

97.9

857

3978

AP1

Catheterization of the left side of the heart

3.2

97.0

403

1296

FKC60

NOMESCO Finland

Resection and reconstruction of leaflet of mitral valve for insufficiency

9.4

96.5

115

123

PD5BD

NOMESCO Finland

Extensive CT of aorta

2.9

95.7

463

1624

AH3

Treatment of arrhythmias, eg atrial fibrillation, in conjunction with other cardiac surgery

19.0

94.2

3A064, ,

NOMESCO Finland

7.3

93.7

138

191

Z94.1

ICD-10 Finland

Heart transplant status

10.8

91.8

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

91.6

1060

5466

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

90.7

3333

23563

FPG30

NOMESCO Finland

Implantation of cardioverter-defibrillator with ventricular electrode

5.1

90.6

191

377

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

3.5

90.3

319

928

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

2.5

90.2

612

2544

M10

ICD-10 Finland

Gout

2.0

88.0

962

4859

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.7

87.7

1880

11697

FPH10

NOMESCO Finland

Open removal of transvenous cardiac pacemaker or cardioverter-defibrillator

10.2

87.6

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

86.9

1861

11574

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.4

84.7

599

2536

I44.2

ICD-10 Finland

Atrioventricular block, complete

2.4

82.2

602

2589

FPW96

NOMESCO Finland

Other operation for arhythmia or disturbance of impulse propagation

5.4

82.1

161

298

FPB22

NOMESCO Finland

Transvenous radiofrequency ablation of aberrant pathway or focus of heart

8.1

81.5

109

135

FM1GD

NOMESCO Finland

CT of pulmonary arteries and left atrium

26.7

81.5

N02AX02

ATC

tramadol; systemic, rectal

1.4

81.2

6826

55875

742, ,

NOMESCO Finland

8.7

81.1

102

117

R03AC02

ATC

salbutamol; inhalant

1.4

80.2

7493

62332

FPE96

NOMESCO Finland

Other implantation or replacement of transvenous cardiac pacemaker

5.6

80.0

152

273

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.5

80.0

3686

27163

WVA20

NOMESCO Finland

Medicine administration

2.6

79.3

485

1919

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

78.9

3396

24693

FNA01

NOMESCO Finland

Anastomosis to coronary artery from internal mammary artery, one distal anastamosis

1.9

78.8

1025

5493

R31

ICD-10 Finland

Unspecified haematuria

1.6

78.6

2019

13125

R06

ICPC

Nose bleed/epistaxis

2.6

78.4

481

1906

R2110

NOMESCO Finland

Giving the first information

2.0

78.4

843

4229

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.8

78.3

1295

7482

S18

ICPC

Laceration/cut

1.4

77.9

7361

61240

Initial pacemaker installation

5.3

77.6

157

299

AS2

Ventricular pacemaker insertion VVI (R)

4.5

77.1

188

419

A10BK01

ATC

dapagliflozin; oral

1.8

77.0

1274

7360

A98

ICPC

Health maint/preventive medicine

1.7

76.7

14982

141222

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

76.2

2662

18538

B60

ICPC

Blood and Immunity, Result test/procedure

3.4

75.4

280

841

A10BK03

ATC

empagliflozin; oral

1.7

75.3

1693

10640

C10AA05

ATC

atorvastatin; oral

1.4

75.1

7451

62325

E06.4

ICD-10 Finland

Drug-induced thyroiditis

36.2

75.0

M10.0

ICD-10 Finland

Idiopathic gout

2.1

74.8

747

3644

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

3.1

73.5

317

1042

-60

ICPC

Result test/procedure

1.9

72.3

938

5019

FPE40

NOMESCO Finland

Replacement of transvenous cardiac pacemaker electrode

5.2

72.1

149

289

XF614

NOMESCO Finland

Measurement of pulmonary artery pressure

8.6

71.5

106

Q23.11

ICD-10 Finland

Bicuspid aortic valve

4.3

71.2

187

442

Z95.8

ICD-10 Finland

Presence of other cardiac and vascular implants and grafts

5.0

71.1

152

304

AB2

AVR bio, stent

4.2

70.3

190

459

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

70.2

1192

6932

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.9

69.6

952

5182

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.2

69.3

626

2937

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

69.1

2435

16950

TFP00

NOMESCO Finland

Temporary use of transvenous or epicardial pacemaker

3.3

69.0

264

808

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

68.9

625

2937

ZSF00

NOMESCO Finland

Procedure related to previous procedure classified in chapter F

7.7

68.8

125

WX740

NOMESCO Finland

Nitrogen oxide therapy

11.5

68.6

R53

ICD-10 Finland

Malaise and fatigue

1.4

68.6

3342

24779

WX722

NOMESCO Finland

PEEP

1.9

68.1

838

4403

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.2

68.0

575

2627

FM1BD

NOMESCO Finland

Extensive CT of heart

6.8

67.7

105

154

WX419

NOMESCO Finland

Other general anesthesy

3.9

67.7

198

507

C03AA03

ATC

hydrochlorothiazide; oral

1.6

67.2

1620

10342

7AX01, ,

NOMESCO Finland

33.1

66.9

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

66.7

9926

87481

FWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in surgery of heart and major thoracic vessels

4.0

66.4

188

470

SPAT1325

SPAT

Vaccination

1.4

66.1

5435

43905

A60

ICPC

General and Unspecified, Result test/procedure

2.1

66.1

687

3401

Q21.10

ICD-10 Finland

Persistent ostium secundum

7.7

65.0

119

FMD00

NOMESCO Finland

Replacement of aortic valve using mechanical prosthesis

3.8

65.0

200

531

T92

ICPC

Gout

2.4

64.2

445

1867

Initial installation of the atrial pacemaker

7.2

63.9

133

S97

ICPC

Chronic ulcer skin

1.8

63.9

1110

6494

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

63.5

1606

10368

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.4

62.6

3633

27707

I25.2

ICD-10 Finland

Old myocardial infarction

1.7

62.3

1312

8087

FPG40

NOMESCO Finland

Replacement of pulse generator in transvenous cardioverter-defibrillator

7.4

62.3

122

FCA60

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of composite graft with mechanical valve prosthesis

6.0

60.6

106

176

XF620

NOMESCO Finland

Examination of circulation with color method

6.0

60.6

106

176

FPJ04

NOMESCO Finland

Revision of pacemaker generator with atrial and ventricular electrodes

4.5

60.1

148

333

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.8

59.2

935

5317

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

59.1

1204

7354

XF622

NOMESCO Finland

Measurement of minute volume of heart

6.0

58.7

104

175

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

58.5

4551

36299

C08CA02

ATC

felodipine; oral

1.6

58.1

1706

11385

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

58.1

6926

58684

I25.5

ICD-10 Finland

Ischaemic cardiomyopathy

2.5

58.0

367

1476

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

57.9

1204

7392

SPAT1260

SPAT

Consultation of another employee

1.4

57.4

2654

19409

C10AA01

ATC

simvastatin; oral

1.3

57.4

7724

66478

AS8

Physiological arrhythmia pacemaker insertionDDD (R) S

7.6

57.0

105

AH2

Treatment of atrial fibrillation by maze surgery or its modification as the only procedure

22.1

56.9

L17

ICPC

Foot/toe symptom/complaint

1.4

56.8

4133

32597

WX780

NOMESCO Finland

Remote monitoring CPAP

2.0

56.7

631

3200

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.9

56.7

746

4006

I20.09

ICD-10 Finland

Unstable angina

1.7

56.7

1076

6447

AC2

MVR bio

10.7

56.3

I34.2

ICD-10 Finland

Nonrheumatic mitral (valve) stenosis

5.4

56.0

110

204

J01FF01

ATC

clindamycin; systemic

1.4

55.3

3840

30048

AA1

Conventional CABG

2.3

55.0

427

1882

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.9

54.9

672

3523

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.7

54.8

1198

7449

TFP33

NOMESCO Finland

Simple electrophysiological investigation (e.g. ventricular stimulation)

11.7

54.7

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

54.7

4861

39447

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

54.6

2572

18854

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

54.6

1160

7158

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

1.9

54.4

691

3666

SPAT1255

SPAT

Intravenous administration of medicine

1.7

54.1

1112

6803

I42.8

ICD-10 Finland

Other cardiomyopathies

4.7

53.9

124

264

FXL00

NOMESCO Finland

Insertion and use of extra-, para- or intracorporeal VAD

13.1

53.4

Catheterization and pressure measurement of the right side of the heart

5.2

53.2

110

214

I45.9

ICD-10 Finland

Conduction disorder, unspecified

3.3

53.1

197

592

WX723

NOMESCO Finland

CPAP therapy

2.0

52.4

584

2964

A91

ICPC

Abnormal result investigation NOS

1.9

52.2

741

4075

R58

ICD-10 Finland

Haemorrhage, not elsewhere classified

2.8

52.1

272

995

I27.2

ICD-10 Finland

Other secondary pulmonary hypertension

4.3

50.9

130

301

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.6

50.8

1302

8412

FP1E5

NOMESCO Finland

ECG, with computer analysis

93.5

50.8

E66.00

ICD-10 Finland

Metabolic syndrome

1.8

50.6

809

4612

FPJ02

NOMESCO Finland

Revision of ventricular pacemaker generator

6.2

50.6

139

XF409

NOMESCO Finland

Other special ECG

4.0

50.5

142

354

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

50.4

5621

46919

ZXE40

NOMESCO Finland

More than seven and less than nine hours

2.3

50.4

398

1768

FPJ22

NOMESCO Finland

Revision of cardioverter-defibrillator with atrial and ventricular electrodes

8.3

50.3

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

50.2

736

4089

SPAT1281

SPAT

Other administrative function

1.6

50.1

1127

7054

M01AE01

ATC

ibuprofen; systemic, rectal

0.8

50.1

11363

122053

FPE24

NOMESCO Finland

Implantation of biventricular cardiac pacemaker, ventricular electrodes, CRT-P (VVIR)

8.9

49.9

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.5

49.7

1891

13299

P06

ICPC

Sleep disturbance

1.6

49.6

1363

8949

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

49.5

827

4778

A11

ICPC

Chest pain NOS

1.6

49.3

1280

8291

I97.0

ICD-10 Finland

Postcardiotomy syndrome

4.7

49.3

113

240

H11.3

ICD-10 Finland

Conjunctival haemorrhage

1.9

49.0

680

3712

R60.0

ICD-10 Finland

Localized oedema

1.5

48.9

1940

13749

UJF32

NOMESCO Finland

Coloscopy

1.3

48.9

4111

32984

Z95.3

ICD-10 Finland

Presence of xenogenic heart valve

3.8

48.7

150

399

A04

ICPC

Weakness/tiredness general

1.5

48.5

1996

14244

FCA70

NOMESCO Finland

Resection of aortic root and ascending aorta with reimplantation of coronary arteries and use of biological valve prosthesis and tube graft

5.5

48.5

169

FPG04

NOMESCO Finland

Insertion of internal defibrillator, atrial and chamber electrode

15.6

48.4

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

48.4

1973

14057

A08

ICPC

Swelling

1.8

48.2

813

4709

TFC20

NOMESCO Finland

Catheterisation of both sides of heart

7.8

47.8

R05

ICPC

Cough

1.4

47.7

3117

24076

C09AA04

ATC

perindopril; oral

1.7

47.7

886

5272

AJ1

Reconstruction of the aortic base, eg composite graft, incl. valve saving operation

6.7

47.6

112

2BD01, ,

NOMESCO Finland

7.0

47.6

103

SPAT1081

SPAT

Cardiorespiratory global assessment

1.7

47.5

953

5788

R50.9

ICD-10 Finland

Fever, unspecified

1.4

47.4

2110

15278

J01FA06

ATC

roxithromycin; oral

1.3

47.4

5340

44540

3AC01, ,

NOMESCO Finland

3.3

47.2

180

551

FNC10

NOMESCO Finland

Aorto-coronary venous bypass with single distal anastomosis

2.6

46.7

284

1121

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

46.6

1186

7644

J01AA02

ATC

doxycycline; systemic

1.3

46.6

11478

105326

Z95.4

ICD-10 Finland

Presence of other heart-valve replacement

5.1

46.5

194

FKC96

NOMESCO Finland

Other repair of mitral valve for insufficiency

6.5

46.4

115

SPAT1353

SPAT

Intensive monitoring

4.0

46.2

129

320

I34.8

ICD-10 Finland

Other nonrheumatic mitral valve disorders

6.8

45.9

104

K07

ICPC

Swollen ankles/oedema

1.7

45.3

782

4558

213

Kela drug reimbursment

Fat metabolism disorder associated with chronic coronary artery disease

1.5

44.9

1321

8797

E66.8

ICD-10 Finland

Other obesity

1.9

44.7

545

2852

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

44.7

2231

16471

B01AB04

ATC

dalteparin; parenteral

1.7

44.4

791

4650

FN1CC

NOMESCO Finland

Very extensive angiography of heart and/or coronary arteries

2.4

44.4

307

1287

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.4

44.1

1860

13321

C09CA01

ATC

losartan; oral

1.3

44.1

4112

33381

FFM30

NOMESCO Finland

Occlusion of atrial appendage internally by internal suture ligation

14.3

44.0

A29

ICPC

General symptom/complaint other

1.4

43.8

1846

13217

SPAT1251

SPAT

Organisation of medication

1.9

43.6

540

2840

R04.2

ICD-10 Finland

Haemoptysis

1.9

43.6

609

3332

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

43.0

727

4212

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

43.0

824

4944

N05CF01

ATC

zopiclone; oral

1.3

42.8

4719

39123

A97

ICPC

No disease

1.4

42.7

2480

18762

FL1AC

NOMESCO Finland

Left cardioangiography

2.3

42.7

330

1453

TFP52

NOMESCO Finland

Ablation treatment of ventricular tachycardia due to structural heart defect

9.8

42.5

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.8

42.5

617

3416

I20.90

ICD-10 Finland

Angina pectoris, unspecified

1.8

42.4

636

3556

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

42.3

1834

13194

FN1CD

NOMESCO Finland

Very extensive CT of coronary arteries

3.8

42.0

127

334

J01MA12

ATC

levofloxacin; systemic

1.3

41.6

2900

22560

FPE36

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with ventricular electrodes

8.7

41.2

SPAT1254

SPAT

Administration of medicine

1.4

41.0

2210

16510

74642

ICD-8 Finland

Congenital anomalies of heart, Defectus septi atriorum, ostium secundum

9.4

40.5

AP4

Myocardial biopsy

8.1

40.4

TK800

NOMESCO Finland

Hemodialysis

2.2

40.3

364

1708

AD1

TVP

8.6

40.3

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

40.0

1796

12996

PD5CG

NOMESCO Finland

Extensive MRI examination of thoracal and abdominal aortta with high intensity magnet

5.2

40.0

155

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

39.7

993

6369

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.4

39.5

1743

12571

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.6

39.3

884

5525

C09CA03

ATC

valsartan; oral

1.5

39.2

1497

10508

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

39.1

2523

19380

-69

ICPC

Other reason for encounter NEC

1.8

39.1

558

3073

-34

ICPC

Blood test

2.0

39.0

404

1997

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

38.8

9069

81689

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.3

38.5

2923

22990

I33.0

ICD-10 Finland

Acute and subacute infective endocarditis

3.3

38.5

143

431

I45.6

ICD-10 Finland

Pre-excitation syndrome

4.3

38.5

227

127

Kela drug reimbursment

Transplant complication

2.5

38.4

236

937

AC1

MVR mechanical

11.8

38.4

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

38.2

4048

33289

I47.0

ICD-10 Finland

Re-entry ventricular arrhythmia

5.4

38.2

136

C07AG02

ATC

carvedilol; oral

1.6

38.1

994

6437

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

37.9

787

4820

XF602

NOMESCO Finland

Bloodpressure monitoring

2.6

37.6

212

808

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

37.5

4625

38736

K92.1

ICD-10 Finland

Melaena

1.6

37.4

892

5653

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

1.8

37.3

599

3418

FEB10

NOMESCO Finland

Decompression and drainage of pericardium

4.7

37.3

180

M79.6

ICD-10 Finland

Pain in limb

1.3

37.3

5495

46976

I42.5

ICD-10 Finland

Other restrictive cardiomyopathy

9.8

37.3

FXF00

NOMESCO Finland

Decannulation after ECHLA or ECLA

13.5

37.2

FM1JR

NOMESCO Finland

Heart, extensive metabolic PET with CT

7.1

37.1

WX730

NOMESCO Finland

Conventional respirator

2.4

37.0

265

1130

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

36.7

4440

37078

R42

ICD-10 Finland

Dizziness and giddiness

1.3

36.7

3365

27144

ATX

Other pacemaker replacement or related action, such as cord removal or replacement

5.4

36.5

131

E05.0

ICD-10 Finland

Thyrotoxicosis with diffuse goitre

2.2

36.4

299

1351

ZXA10

NOMESCO Finland

Bilateral

1.3

36.3

2698

21141

I46.0

ICD-10 Finland

Cardiac arrest with successful resuscitation

2.3

36.2

274

1196

FM1AD

NOMESCO Finland

CT of heart

4.4

36.1

201

AS7

Arrhythmia pacemaker insertion VVI (R) S

5.1

36.0

147

ZXA00

NOMESCO Finland

Right side

1.3

35.9

3975

32828

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

35.7

808

5055

A40.8

ICD-10 Finland

Other streptococcal sepsis

2.7

35.7

186

681

I83.9

ICD-10 Finland

Varicose veins of lower extremities without ulcer or inflammation

1.5

35.6

1235

8499

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

35.5

3297

26619

C09AA02

ATC

enalapril; systemic

1.3

35.2

3215

25896

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.5

34.9

1006

6660

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.4

34.8

2123

16139

SPAT1252

SPAT

Overall medication plan or its review

1.5

34.8

1080

7266

-50

ICPC

Medication/prescr/renewal

1.7

34.7

597

3474

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.2

34.7

7110

62828

Q21.09

ICD-10 Finland

Ventricular septal defect NOS

8.3

34.6

SPAT1310

SPAT

Counselling related to known health issue

1.3

34.3

4394

36884

N19

ICD-10 Finland

Unspecified kidney failure

1.7

34.1

609

3581

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

34.1

2156

16477

L28

ICPC

Limited function/disability (L)

1.3

34.1

2740

21683

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

34.0

9248

84053

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.6

33.9

780

4899

FCA50

NOMESCO Finland

Resection and reconstruction of ascending aorta using tube graft

3.9

33.9

254

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

33.9

3484

28468

K34

ICPC

Cardiovascular, Blood test

4.4

33.8

195

R55

ICD-10 Finland

Syncope and collapse

1.4

33.7

1720

12704

SPAT1336

SPAT

Request for examination

1.8

33.6

505

2826

A99

ICPC

Disease/condition unspecnature/site

1.5

33.6

1276

8938

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

33.5

383

1962

Q21.00

ICD-10 Finland

Multiple ventricular septal defect

10.0

33.5

Mitral valve plasty

7.6

33.4

M01AX05

ATC

glucosamine; oral

1.3

33.3

3001

24104

I20.00

ICD-10 Finland

Unstable angina

1.8

33.3

517

2922

ZXA05

NOMESCO Finland

Left side

1.3

33.2

3680

30339

C08CA13

ATC

lercanidipine; oral

1.3

33.2

2280

17637

Coronary artery bypass surgery

1.9

33.1

399

2081

-44

ICPC

Preventive immunization/medic

1.5

32.8

1225

8552

H26.4

ICD-10 Finland

After-cataract

1.4

32.7

1609

11807

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.4

32.7

1379

9850

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

32.5

2699

21438

C07AB04

ATC

acebutolol; systemic

2.2

32.4

282

1305

K02.1

ICD-10 Finland

Caries of dentine

1.2

32.4

7265

64620

L15

ICPC

Knee symptom/complaint

1.3

32.4

3087

24969

FPE37

NOMESCO Finland

Implantation of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

4.3

32.3

194

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

1.8

32.0

524

3007

U06

ICPC

Haematuria

1.9

32.0

422

2267

L04AD02

ATC

tacrolimus; systemic

3.0

32.0

143

482

K87

ICPC

Hypertension complicated

1.9

32.0

424

2282

H25.1

ICD-10 Finland

Senile nuclear cataract

1.2

32.0

4653

39550

TFJ02

NOMESCO Finland

Muscle biopsy of heart

5.9

31.9

FC1BC

NOMESCO Finland

Extensive angiography of thoracal aortta

4.9

31.9

140

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.1

31.8

306

1473

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.7

31.8

584

3462

K48

ICPC

Cardiovascular, Clarification/discussion RFE/demand

3.5

31.8

108

308

R07.3

ICD-10 Finland

Other chest pain

1.4

31.8

1388

9974

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

2.6

31.7

184

712

FFC00

NOMESCO Finland

Suture of ostium secundum type ASD

9.3

31.7

WZC30

NOMESCO Finland

Teaching

1.3

31.7

2264

17606

D68.3

ICD-10 Finland

Haemorrhagic disorder due to circulating anticoagulants

3.8

31.6

245

J01FA10

ATC

azithromycin; systemic

1.2

31.5

6705

59265

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

1.7

31.5

576

3410

Q87.4

ICD-10 Finland

Marfan syndrome

10.3

31.4

I41.8*D86.8

ICD-10 Finland

Sarcoid myocarditis

6.5

31.3

J01DA01

ATC

[U] cefalexin

1.2

31.3

8421

76154

FPB32

NOMESCO Finland

Transvenous radiofrequency ablation of pulmonary vein pathway or focus

39.0

31.1

WX703

NOMESCO Finland

Insertion of pharyngeal or nasopharyngeal tube

10.0

30.8

F1279, ,

NOMESCO Finland

10.0

30.8

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

1.6

30.7

692

4327

FPJ24

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with atrial and ventricular electrodes

5.6

30.6

101

Q21.19

ICD-10 Finland

Atrial septal defect NOS

5.2

30.5

119

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

30.5

410

2216

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

30.5

793

5128

S29

ICPC

Skin symptom/complaint other

1.3

30.5

2608

20780

Mitral valve Replacement (MVR)

9.0

30.2

A02BC05

ATC

esomeprazole; systemic

1.2

30.1

5570

48475

T82

ICPC

Obesity

1.9

30.1

360

1874

T90

ICPC

Diabetes non-insulin dependent

1.2

29.9

3895

32652

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

29.9

1098

7636

N06AX11

ATC

mirtazapine; oral

1.2

29.9

4347

36888

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

29.8

1139

7982

K28

ICPC

Limited function/disability (K)

1.9

29.8

377

1999

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

29.7

3521

29199

FFM32

NOMESCO Finland

Occlusion or excision of atrial appendage transvenously with a closing device

5.8

29.4

R03BA02

ATC

budesonide; inhalant

1.3

29.4

2088

16208

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.7

29.4

585

3544

ECB00

NOMESCO Finland

Suture of gingiva

1.7

29.3

498

2890

I31.9

ICD-10 Finland

Disease of pericardium, unspecified

3.0

29.2

129

432

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.4

29.2

1536

11389

C09CA06

ATC

candesartan; oral

1.3

29.1

3161

25936

FPJ23

NOMESCO Finland

Revision of biventricular cardioverter-defibrillator with ventricular electrodes

10.0

29.0

Z2446

NOMESCO Finland

Social worker

1.6

28.5

738

4766

L04AA06

ATC

mycophenolic acid; systemic

2.2

28.5

251

1168

FFW96

NOMESCO Finland

Other operation on atria

5.5

28.0

FXD00

NOMESCO Finland

Use of ECHLA without concurrent surgical procedure

7.9

28.0

AB1

AVR mechanical

3.7

27.9

239

74639

ICD-8 Finland

Congenital anomalies of heart, Defectus septi ventriculorum

9.4

27.8

SPAT1301

SPAT

No procedures

1.2

27.8

4519

38735

L04

ICPC

Chest symptom/complaint

1.6

27.8

757

4946

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

1.7

27.8

483

2821

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

27.7

1389

10214

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.3

27.6

1978

15362

S16

ICPC

Bruise/contusion

1.8

27.6

436

2477

I71.00

ICD-10 Finland

Dissecting aneurysm of aorta (ruptured) [any part]

3.4

27.6

288

FKE60

NOMESCO Finland

Repair of mitral valve regurgitation with transvenously implanted clip

8.9

27.6

Z95.5

ICD-10 Finland

Presence of coronary angioplasty implant and graft

1.6

27.5

662

4203

WVA50

NOMESCO Finland

Pharmacological cardioversion

28.5

27.5

I31.3

ICD-10 Finland

Pericardial effusion (noninflammatory)

4.1

27.4

180

B80

ICPC

Iron deficiency anaemia

2.0

27.3

298

1503

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

27.2

1554

11671

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

27.1

527

3173

FNC20

NOMESCO Finland

Aorto-coronary venous bypass with two distal anastomoses

1.8

27.0

389

2151

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.7

26.8

524

3159

SPAT1079

SPAT

Echocardiography

2.3

26.6

208

923

A10

ICPC

Bleeding/haemorrhage NOS

2.7

26.5

140

517

GE1BE

NOMESCO Finland

Mediastinal ultrasound examinaiton through oesophagus

5.2

26.5

104

FPH96

NOMESCO Finland

Other removal of cardiac pacemaker or cardioverter-defibrillator

3.4

26.5

276

M54.5

ICD-10 Finland

Low back pain

1.2

26.4

4363

37418

WZC00

NOMESCO Finland

Treatment plan or consultation

1.2

26.4

4784

41414

FN1CB

NOMESCO Finland

Coronary flow reserve measurement with pressure wire

1.8

26.3

424

2424

ZX108

NOMESCO Finland

Inhalation

2.9

26.3

122

421

ZXE60

NOMESCO Finland

More than 12 and less than 15 hours

2.8

26.3

127

448

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

6.7

26.2

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.6

26.2

665

4277

FK1BT

NOMESCO Finland

Implantation of cardiac pacemaker with X-ray guidance

3.6

26.2

231

TFN04, ,

NOMESCO Finland

3.2

26.2

105

333

I49

ICD-10 Finland

Other cardiac arrhythmias

2.3

26.1

191

824

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.8

25.9

401

2265

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

25.7

1879

14629

K50

ICPC

Cardiovascular, Medication/prescr/renewal

3.4

25.6

268

Z01.7

ICD-10 Finland

Laboratory examination

1.3

25.6

1774

13708

ASB

Insertion of a biventricular physiological pacemaker DDD (R)

5.8

25.6

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.4

25.5

1274

9357

J01CF05

ATC

flucloxacillin; systemic

1.5

25.5

755

5025

AR2

Catheter ablation of arrhythmia, target: extra pathway (WPW, AVRT, PJRT)

6.8

25.3

B01AB10

ATC

tinzaparin; parenteral

1.4

25.1

1321

9787

H02AB07

ATC

prednisone; oral

1.3

25.0

1787

13861

A10BH05

ATC

linagliptin; oral

1.5

25.0

836

5706

PD5AD

NOMESCO Finland

CT of aorta

1.8

25.0

354

1948

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.6

25.0

618

3951

FPG42

NOMESCO Finland

Replacement of electrode(s) in transvenous cardioverter-defibrillator

8.9

25.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

1.8

24.9

400

2284

U02

ICPC

Urinary frequency/urgency

1.3

24.9

1658

12731

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

24.8

880

6074

R4120

NOMESCO Finland

Occupational therapy

1.5

24.7

803

5448

SPAT1377

SPAT

Polysomnography

1.7

24.7

413

2387

ZXD00

NOMESCO Finland

Emergency procedure

1.7

24.6

412

2381

A62

ICPC

General and Unspecified, Administrative procedure

1.8

24.4

339

1853

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

1.8

24.4

349

1925

S21

ICPC

Skin texture symptom/complaint

1.3

24.4

1906

14965

-62

ICPC

Administrative procedure

1.8

24.4

363

2028

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

24.3

8074

73664

J45.1

ICD-10 Finland

Nonallergic asthma

1.5

24.3

891

6191

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

1.9

24.3

286

1483

Catheterization and pressure measurement of the left side of the heart

1.9

24.2

284

1470

N17

ICPC

Vertigo/dizziness

1.3

24.2

1630

12535

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

24.1

5398

47576

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.4

24.0

1027

7345

DKW00

NOMESCO Finland

Cauterisation of mucosa of nose

2.3

23.9

174

750

XFP02, ,

NOMESCO Finland

5.6

23.8

WX720

NOMESCO Finland

Own respiration

1.6

23.6

624

4051

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

23.6

1111

8078

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.2

23.6

4667

40644

PC1BD

NOMESCO Finland

Extensive CT of thoracic aorta

3.0

23.5

100

329

ZXE90

NOMESCO Finland

More than 22 hours

2.7

23.5

124

459

SFA20

NOMESCO Finland

Two-surface restoration

1.2

23.5

7095

64141

FP1C5

NOMESCO Finland

Resting ECG, 15 leads

2.3

23.4

178

781

K24

ICPC

Fear of heart disease

1.8

23.4

364

2060

M25.0

ICD-10 Finland

Haemarthrosis

2.3

23.4

174

757

C02AC05

ATC

moxonidine; oral

1.5

23.4

713

4775

SPAT1312

SPAT

General health counselling

1.2

23.3

4039

34721

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.4

23.3

1385

10457

I36.0

ICD-10 Finland

Nonrheumatic tricuspid (valve) stenosis

7.2

23.2

ZYC01

NOMESCO Finland

Remote contact by phone

1.5

23.2

670

4436

WX890

NOMESCO Finland

Intesive care monitoring

2.7

23.0

125

469

TK810

NOMESCO Finland

Hemofiltration

2.8

23.0

112

397

C10AX09

ATC

ezetimibe; oral

1.3

22.8

2379

19361

FM1CG

NOMESCO Finland

Extensive examination of hear with high intensity magnet

3.6

22.8

210

AR1

Catheter ablation of arrhythmia, target: AV node reentry activation (AVNRT)

4.0

22.8

156

I35.9

ICD-10 Finland

Aortic valve disorder, unspecified

2.8

22.6

114

412

3A149, ,

NOMESCO Finland

9.3

22.5

R05

ICD-10 Finland

Cough

1.2

22.5

2678

22125

5AB14, ,

NOMESCO Finland

5.9

22.5

J01MA02

ATC

ciprofloxacin; systemic

1.2

22.4

5815

51817

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

2.1

22.4

204

964

FM1DM

NOMESCO Finland

Heart very extensive MRI examination with 3 Tesla magnet

6.7

22.4

FPH00

NOMESCO Finland

Transvenous extraction of transvenous cardiac pacemaker or cardioverter-defibrillator

6.9

22.4

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

2.5

22.4

137

546

A03

ICPC

Fever

1.3

22.3

1586

12284

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

22.3

6075

54353

XF405

NOMESCO Finland

Symptom ECG

2.7

22.2

114

416

D07AC01

ATC

betamethasone; topical

1.2

22.2

4847

42543

WX882

NOMESCO Finland

High dependency care

1.7

22.1

393

2312

SPAT1153

SPAT

Removal of sutures

1.2

21.9

4697

41138

S80.0

ICD-10 Finland

Contusion of knee

1.5

21.8

715

4860

I31.1

ICD-10 Finland

Chronic constrictive pericarditis

8.5

21.8

S76

ICPC

Skin infection other

1.5

21.8

704

4771

I20.8

ICD-10 Finland

Other forms of angina pectoris

2.4

21.8

144

595

FP2H5

NOMESCO Finland

ECG, telemetry

5.3

21.7

A02BC01

ATC

omeprazole; systemic

1.2

21.6

3762

32310

N05BA04

ATC

oxazepam; oral

1.2

21.6

3168

26749

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

21.6

744

5108

R03BB04

ATC

tiotropium bromide; inhalant

1.3

21.5

1541

11949

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.9

21.5

273

1453

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

1.4

21.4

897

6388

Aortic Valve Replacement (AVR)

4.6

21.1

106

I33.9

ICD-10 Finland

Acute endocarditis, unspecified

4.5

21.1

114

FN1AT

NOMESCO Finland

Endovascular dilatation of coronary arteries (PTCA)

1.5

21.1

777

5404

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

21.1

4339

37839

FN1BT

NOMESCO Finland

Extensive endovascular dilatation of coronary (PTCA) arteries

1.7

21.1

367

2147

WX320

NOMESCO Finland

Spinalanesthesy

1.2

21.1

3411

29082

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

1.8

21.1

300

1655

JN3AD

NOMESCO Finland

Abdominal CT examination

1.3

21.0

1578

12309

I95.9

ICD-10 Finland

Hypotension, unspecified

2.0

21.0

239

1226

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

1.7

21.0

384

2277

I20.01

ICD-10 Finland

Unstable angina

1.6

21.0

492

3107

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

21.0

318

5433

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

1.8

20.9

334

1906

E0000UV, ,

ATC

1.2

20.9

5223

46317

L03

ICPC

Low back symptom/complaint

1.2

20.9

3262

27706

-42

ICPC

Electrical tracing

2.0

20.9

216

1071

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

0.4

20.8

2320

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.9

20.8

278

1504

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

20.7

1221

9198

3A422, ,

NOMESCO Finland

6.6

20.7

FKC00

NOMESCO Finland

Repair of mitral valve for insufficiency using ring

5.6

20.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.3

20.7

1940

15573

R03BA05

ATC

fluticasone; inhalant

1.3

20.7

2036

16444

SFA10

NOMESCO Finland

One-surface restoration

1.2

20.6

6712

60813

FNC30

NOMESCO Finland

Aorto-coronary venous bypass with three distal anastomoses

1.8

20.6

295

1631

WX870

NOMESCO Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3021589) Normoblasts [#/volume] in Blood

8401

59027

1.87

320.01

13.4

10.4

0.00

e9/l

0.13

6992

48325

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4338

24546

2.04

316.84

4.3

3.3

0.81

mmol/l

0.50

4062

22830

(3004789) Transferrin [Mass/volume] in Serum or Plasma

4043

22385

2.07

312.85

2.9

2.6

2.35

2.25

g/l

24.33

3779

20618

(3022948) Iron [Moles/volume] in Serum or Plasma

4258

24045

2.04

311.98

3.0

2.6

12.26

12.46

umol/l

0.97

4002

22253

(3027456) Digoxin [Moles/volume] in Serum or Plasma

2222

2740

9.21

307.65

3.2

3.0

0.79

0.82

nmol/l

1.11

1828

2049

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

9397

47614

3.29

307.65

4.8

3.0

2028.86

1580.91

ng/l

19.78

8640

41117

(3024928) Oxygen saturation in Venous blood

1127

3065

3.87

307.65

3.4

3.2

—

(3022217) INR in Platelet poor plasma by Coagulation assay

13050

72981

4.96

307.65

41.9

15.5

1.72

1.30

inr

209.22

4195

20088

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

9244

57948

2.37

307.65

5.7

3.9

42.53

79.50

ng/l

2.37

7545

44484

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

3960

21150

2.15

307.65

3.0

2.6

21.02

22.27

6.94

3503

17770

(3044889) 12 lead EKG panel

12662

97582

2.33

307.65

7.4

4.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

5429

29730

2.23

307.65

5.3

4.0

426.54

547.47

ng/l

1.35

4991

25187

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1885

6083

3.37

307.65

3.9

3.2

4.21

4.41

pmol/l

14.44

1742

5292

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12206

95058

2.12

307.65

4.7

3.7

15.49

15.01

pmol/l

73.76

11200

84276

(3014111) Lactate [Moles/volume] in Serum or Plasma

2972

13897

2.39

307.65

9.0

6.7

1.35

1.38

mmol/l

1.18

2884

13527

(3000991) Gas panel - Venous blood

2869

13237

2.41

307.65

10.2

8.1

—

(3019230) Fractional oxyhemoglobin in Venous blood

1049

2361

4.67

307.65

3.3

2.8

63.37

64.25

0.56

1043

2347

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3298

13983

2.70

307.65

4.0

2.9

327.45

214.70

ng/l

30.19

3071

12836

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1879

7196

2.81

307.65

4.2

4.3

24.23

24.03

mmol/l

2.09

1837

7026

(3013826) Glucose [Moles/volume] in Serum or Plasma

11688

86021

2.26

307.65

7.0

5.0

6.72

6.92

mmol/l

23.42

11265

81140

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1565

5819

2.86

296.24

3.9

2.9

0.36

0.35

u/ml

0.43

976

3272

(3024354) Oxygen [Partial pressure] in Venous blood

2544

12107

2.30

286.48

3.6

3.2

4.55

4.52

kpa

0.30

2461

11706

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2947

14916

2.19

285.43

4.3

3.9

5.85

5.81

kpa

1.10

2862

14507

(3012544) pH of Venous blood

3015

15523

2.15

278.96

4.3

4.0

7.39

7.38

0.12

116

(3002032) Base excess in Venous blood by calculation

2917

14903

2.16

274.90

4.3

4.0

1.72

1.85

mmol/l

1.19

2614

12577

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2073

9246

2.42

269.80

9.5

6.9

24.95

24.74

mmol/l

1.66

2060

9156

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1764

7369

2.56

264.13

3.2

2.8

1.09

1.23

7.67

1755

7333

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13939

118873

2.19

261.94

5.8

4.5

2.08

2.18

mu/l

1.29

12948

106160

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

9804

75222

1.76

250.68

6.8

6.5

14.39

12.12

umol/l

50.00

9354

71421

(3018677) aPTT in Platelet poor plasma by Coagulation assay

4064

24164

1.90

247.12

2.9

2.0

32.72

29.82

104.40

3950

23445

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

9040

68023

1.73

245.46

8.0

6.3

1.20

1.21

mmol/l

55.64

8463

61473

(3020779) Urea [Moles/volume] in Serum or Plasma

2814

14762

2.09

244.76

9.1

7.0

10.90

10.80

mmol/l

0.28

2681

13948

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

14950

132136

2.59

244.09

24.1

16.8

24.75

27.09

mg/l

16.27

13273

107609

(3004119) Hemoglobin [Mass/volume] in Venous blood

2059

9695

2.28

234.53

3.8

3.4

135.57

127.29

g/l

45.51

2021

9446

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7251

51989

1.71

229.08

3.5

2.9

168.85

172.32

ug/l

0.35

6611

47099

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

9643

74718

1.71

227.10

8.6

7.0

1.20

1.21

mmol/l

58.53

8113

63159

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2823

15429

2.00

216.76

4.3

3.7

—

(3023368) Bacteria identified in Blood by Culture

6327

44295

1.70

214.06

5.3

4.4

—

(3002385) Erythrocyte distribution width [Ratio]

13058

111049

1.88

213.78

29.6

19.6

15.28

15.43

1.51

12915

108938

(36304419) Bacteria [Presence] in Urine

5880

40391

1.71

213.32

3.7

3.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2681

14640

1.99

205.32

2.8

2.4

12.05

7.25

ug/l

11.20

2448

12635

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12774

108368

1.82

204.48

8.9

7.9

80.59

80.21

u/l

0.39

12166

101738

(3030467) Casts [#/volume] in Urine by Automated count

6068

42389

1.68

204.41

3.7

3.4

0.64

0.45

e6/l

3.24

4813

32743

(3033658) Prothrombin time (PT) actual/Normal

5373

36423

1.70

202.06

5.2

4.1

66.04

86.79

307.65

5271

35613

(3018418) pH of Serum or Plasma

6210

43939

1.66

197.23

4.7

4.3

7.40

1.19

1488

8257

(3002582) Erythrocytes [#/volume] in Urine

6448

46184

1.65

194.41

3.8

3.5

131.22

105.99

e6/l

0.43

5133

35900

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

5420

37515

1.66

184.33

2.7

2.3

3.30

3.04

mg/l

10.16

4706

31696

(3018095) Leukocytes [#/volume] in Urine

7013

51913

1.61

181.01

4.4

3.9

109.19

108.74

e6/l

0.01

5363

38105

(3013650) Neutrophils [#/volume] in Blood by Automated count

9769

78333

1.61

179.73

8.8

9.2

4.39

4.31

e9/l

2.65

8365

68072

(3001604) Monocytes [#/volume] in Blood

8638

67620

1.58

172.88

6.3

5.8

0.64

0.63

e9/l

6.13

7342

57797

(3006315) Basophils [#/volume] in Blood

8658

67842

1.58

172.33

6.3

5.8

0.04

e9/l

0.55

7367

57994

(3019069) Monocytes/100 leukocytes in Blood

8233

63878

1.58

170.12

6.9

6.4

9.19

8.92

10.93

7729

59375

(3013115) Eosinophils [#/volume] in Blood

8852

69850

1.58

169.88

6.6

6.0

0.19

0.20

e9/l

10.17

7671

60458

(3006504) Eosinophils/100 leukocytes in Blood

8184

63505

1.57

168.30

6.7

6.1

2.71

2.88

10.07

7684

58938

(3000850) Epithelial cells [#/volume] in Urine

4746

32357

1.65

167.77

2.9

2.7

4.35

4.40

e6/l

0.12

4289

28991

(3019198) Lymphocytes [#/volume] in Blood

8774

69270

1.57

166.58

6.4

5.9

1.76

1.91

e9/l

9.11

7621

60483

(3022096) Basophils/100 leukocytes in Blood

7979

61645

1.57

166.57

6.7

6.1

0.64

0.66

2.93

7482

57184

(40761511) CBC panel - Blood by Automated count

14912

135345

2.19

165.80

23.6

15.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5878

42408

1.60

164.17

3.3

35.09

36.35

u/l

0.63

5528

39885

(3002030) Lymphocytes/100 leukocytes in Blood

8328

65135

1.56

163.50

6.8

6.2

24.47

26.27

39.88

7820

60669

(3019550) Sodium [Moles/volume] in Serum or Plasma

15255

139915

2.41

162.44

31.9

19.7

139.59

139.60

mmol/l

0.18

15094

136382

(40760892) CBC W Ordered Manual Differential panel - Blood

8161

63735

1.56

159.80

7.2

6.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2938

17794

1.79

158.87

1.9

1.8

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

15255

140202

2.37

156.60

32.4

19.8

4.03

4.00

mmol/l

48.09

15077

136477

(3027801) Oxygen [Partial pressure] in Arterial blood

3085

19056

1.76

155.51

9.6

7.0

11.59

12.03

kpa

4.52

2927

18136

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

3086

19069

1.76

155.35

9.6

7.0

5.03

5.08

kpa

2.52

2932

18159

(3018010) Neutrophils/100 leukocytes in Blood

8171

64078

1.55

155.22

6.6

6.0

60.04

58.33

30.28

7672

59644

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2929

17836

1.78

155.07

1.9

1.8

—

(3003396) Base excess in Arterial blood by calculation

3083

19054

1.76

155.06

9.6

7.0

0.90

1.08

mmol/l

1.57

2513

15175

(3026782) Osmolality of Urine

4517

30922

1.63

154.58

3.3

3.1

535.13

554.31

mosm/kgh2o

8.18

3933

26531

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14048

125620

1.85

152.22

24.9

15.9

72.11

75.24

ml/min/173m2

63.72

12690

104289

(40758558) Short blood count panel - Blood

4877

34248

1.60

149.21

6.9

7.1

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

3892

25979

1.65

145.80

2.0

1.9

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1686

8754

2.03

145.35

12.8

8.6

24.30

mmol/l

0.01

1599

8443

(3026493) Urate [Moles/volume] in Serum or Plasma

5447

39618

1.56

141.38

3.4

2.9

4670.28

5506.94

umol/l

0.68

4711

33994

(3013512) EKG study

6045

45019

1.54

140.86

7.1

4.2

—

(3016502) Oxygen saturation in Arterial blood

2795

17245

1.74

139.79

10.1

7.3

94.62

95.51

6.57

2706

16580

(3052851) Hemolysis interference index of Serum or Plasma

1019

4392

2.40

139.51

3.6

3.5

—

(3027945) Reticulocytes/100 erythrocytes in Blood

2987

19072

1.69

130.87

2.4

1.84

1.77

3.65

2660

16735

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2553

15689

1.74

128.43

10.8

7.7

122.81

121.07

g/l

3.76

2500

15252

(3014007) Fractional oxyhemoglobin in Arterial blood

1849

10408

1.87

124.48

12.7

8.6

92.63

93.89

7.49

1837

10373

(3031040) Bacteria [#/volume] in Urine by Automated count

10777

91908

1.50

122.79

5.3

4.8

1096.88

1402.79

e6/l

0.32

209

1470

(3024561) Albumin [Mass/volume] in Serum or Plasma

8060

64936

1.47

122.07

5.2

5.0

34.38

34.77

g/l

7.76

7488

60057

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

215

359

6.04

122.05

5.0

5.4

74.79

68.10

3.03

194

280

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

2962

19185

1.66

121.84

4.7

4.2

262.18

245.30

u/l

5.46

2805

18112

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1830

10375

1.86

120.19

12.7

8.6

0.60

0.67

11.32

1821

10308

(3020564) Creatinine [Moles/volume] in Serum or Plasma

15150

140823

2.06

118.56

30.7

19.8

89.51

83.97

umol/l

54.45

15150

140767

(3010421) pH of Blood

918

4077

2.32

116.94

4.6

4.2

7.42

1.08

845

3714

(3042936) Bacteria identified in Isolate by Culture

3201

21360

1.62

116.20

2.3

2.1

—

(40767503) Oxygen content in Capillary blood by calculation

812

3429

2.43

115.91

2.7

2.6

16.14

16.17

0.05

387

1846

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1811

10424

1.82

112.84

12.6

8.5

1.28

1.37

3.79

1800

10353

(3027315) Oxygen [Partial pressure] in Blood

829

3592

2.37

111.67

4.6

4.3

8.39

8.45

kpa

0.51

817

3503

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3080

20604

1.61

109.87

6.5

5.9

1.05

1.03

mmol/l

3.49

2855

19094

(3013290) Carbon dioxide [Partial pressure] in Blood

820

3575

2.36

108.87

4.6

4.3

4.94

4.99

kpa

1.04

808

3487

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

863

3850

2.31

108.64

3.5

2.4

3.60

3.65

g/l

0.48

828

3677

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

13863

126079

1.66

108.63

6.9

6.6

41.04

40.87

mmol/mol

1.29

12857

114796

(3012501) Base excess in Blood by calculation

819

3574

2.35

108.50

4.6

4.3

2.54

2.61

mmol/l

0.26

582

2447

(3028271) Lactate [Moles/volume] in Capillary blood

642

2511

2.61

107.68

2.0

1.9

1.72

mmol/l

0.03

629

2450

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5993

46380

1.46

107.03

2.4

2.2

210.36

229.16

u/l

1.05

5615

43293

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15076

140576

1.95

106.37

14.2

11.3

26.53

26.48

u/l

0.12

14652

134685

(3022806) Fractional oxyhemoglobin in Capillary blood

540

1981

2.78

102.70

2.0

1.9

89.85

89.00

2.47

533

1955

(3037467) Urinalysis macro (dipstick) panel - Urine

10958

95316

1.45

100.48

4.9

4.6

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

772

3415

2.32

98.98

3.9

2.3

211.20

205.92

0.85

730

3239

(40761536) Microorganisms panel - Urine sediment

1879

11346

1.74

98.58

4.7

4.2

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1570

9014

1.82

97.88

13.6

9.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

14.78

97.73

1.7

1.5

0.67

0.68

umol/l

0.03

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

13694

124930

1.59

97.05

4.7

4.3

1.31

mmol/l

0.15

12495

111613

(3013707) Erythrocyte sedimentation rate by Westergren method

11381

100012

1.45

96.31

4.7

4.2

14.79

13.66

mm/h

10.38

10491

91488

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3491

24664

1.52

96.08

3.4

3.2

2.32

1.91

e6/l

1.57

1939

13781

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2007

12476

1.69

94.40

4.3

4.1

1.21

1.23

mmol/l

15.56

1777

10816

(3036489) Thrombin time

968

4807

2.07

92.81

3.2

1.9

23.18

21.84

2.97

890

4296

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

14428

133616

1.68

92.81

5.9

5.4

2.43

2.60

mmol/l

96.83

13314

120945

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14131

130293

1.62

91.12

5.3

4.8

4.20

4.46

mmol/l

171.93

13084

118439

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

807

3773

2.19

90.42

3.7

2.1

85.45

88.36

3.21

787

3619

(3009542) Hematocrit [Volume Fraction] of Blood

15293

144309

1.95

88.68

37.3

24.7

40.32

40.05

3.15

14487

133076

(3007461) Platelets [#/volume] in Blood

15293

144377

1.94

87.51

36.4

24.5

224.81

240.19

e9/l

169.91

15055

139979

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

14004

129095

1.59

87.43

5.2

4.8

1.33

1.41

mmol/l

105.21

12880

116445

(3024731) MCV [Entitic volume]

15294

144427

1.94

86.88

36.3

24.5

92.15

91.60

42.07

15151

141896

(3026361) Erythrocytes [#/volume] in Blood

15294

144432

1.94

86.79

36.4

24.5

4.45

4.46

e12/l

1.30

15000

139446

(3035941) MCH [Entitic mass]

15292

144411

1.94

86.72

36.3

24.4

30.55

30.49

3.50

15145

141883

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

14131

130600

1.60

86.60

5.5

5.1

6.13

6.12

mmol/l

0.80

12807

116978

(3010813) Leukocytes [#/volume] in Blood

15293

144435

1.94

86.52

36.4

24.5

6.97

6.90

e9/l

2.83

15003

139459

(3000963) Hemoglobin [Mass/volume] in Blood

15294

144452

1.94

86.45

36.7

24.7

134.81

135.15

g/l

1.76

15158

141940

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

912

4558

2.06

85.80

1.8

1.7

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3912

28889

1.46

84.82

2.6

1.7

1.32

1.45

mg/l

1.30

2900

22679

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2390

15988

1.58

82.71

2.7

2.8

10.03

9.81

umol/l

0.18

2081

14064

(3021601) Nitrite [Presence] in Urine by Test strip

7922

66301

1.37

82.60

5.4

5.2

0.00

estimate

1.08

2014

12244

(3006184) Hemoglobin [Mass/volume] in Capillary blood

770

3669

2.15

82.12

2.3

130.37

128.80

g/l

0.80

532

2665

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3629

26582

1.47

81.55

3.2

3.0

1.09

1.24

e6/l

0.66

2083

15579

(3035350) Ketones [Presence] in Urine by Test strip

7923

66547

1.37

79.53

4.2

3.9

0.00

estimate

1.28

2107

13195

(3023520) Reticulocytes [#/volume] in Blood

2200

14565

1.59

79.34

2.7

2.5

73.03

68.29

e9/l

6.74

1617

11165

(3009261) Glucose [Presence] in Urine by Test strip

7947

67179

1.35

74.50

4.2

3.9

0.00

estimate

2.60

1920

11820

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

699

3332

2.14

74.38

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

699

3332

2.14

74.38

1.4

1.3

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

131

220

5.98

74.02

1.7

1.5

104.91

123.12

ug/l

0.99

107

183

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1335

7944

1.74

72.66

1.7

1.6

1.43

1.58

g/l

7.97

1116

6774

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7777

65771

1.34

71.48

3.0

2.7

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

9411

81910

1.35

71.20

3.5

3.2

68.63

56.81

u/l

16.63

8680

74716

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

556

2481

2.28

69.62

1.7

1.6

4.25

4.64

iu/l

0.30

174

754

(1616796) Gas panel - Central venous blood

727

3632

2.04

68.23

4.2

3.8

—

(3000492) Spirometry study

1778

11638

1.59

66.47

1.7

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

5613

45616

1.35

65.43

2.9

2.6

—

(3020630) Protein [Mass/volume] in Serum or Plasma

2054

13992

1.53

64.16

2.4

2.6

65.49

66.27

g/l

4.59

1873

12622

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

723

3693

2.00

63.74

1.6

1.5

—

(3026008) Bacteria identified in Urine by Culture

5465

44484

1.34

62.16

3.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

4334

34076

1.37

61.81

4.1

3.7

—

(3021960) Folate [Moles/volume] in Serum or Plasma

4625

36806

1.35

60.82

1.7

1.6

19.32

20.04

nmol/l

2.75

4041

31107

(3007853) Bacteria identified in Skin by Aerobe culture

2391

16991

1.47

60.52

2.0

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

7602

65005

1.31

60.52

2.4

2.3

—

(3025159) Blasts/100 leukocytes in Blood

1654

10898

1.57

59.73

3.9

4.0

0.48

0.36

0.23

464

3323

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1888

12922

1.52

57.22

2.4

2.5

36.02

51.67

u/l

1.52

1632

11064

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1501

9849

1.57

54.96

1.7

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

397

1727

2.33

52.77

1.7

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1649

11145

1.53

52.76

3.7

3.9

0.57

0.70

1.96

509

4000

(3003434) Protein [Mass/volume] in Pleural fluid

516

2504

2.09

52.31

1.6

1.5

28.96

32.68

g/l

9.32

442

2260

(3019060) Gas panel - Arterial blood

1668

11327

1.52

52.16

4.7

4.9

—

(3021440) Promyelocytes/100 leukocytes in Blood

1706

11648

1.52

51.99

3.9

4.0

0.10

0.11

0.14

515

4026

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

2001

14201

1.46

50.21

2.1

2.3

0.20

g/l

3.77

1824

13128

(3017181) Myelocytes/100 leukocytes in Blood

1774

12318

1.49

49.69

3.9

4.0

0.95

0.96

0.08

578

4657

(3029937) Albumin [Presence] in Urine by Test strip

4522

36733

1.32

49.36

4.6

4.3

0.00

estimate

0.24

1872

11506

(3024891) Influenza virus A+B Ag [Presence] in Specimen

573

2950

1.97

49.31

1.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5472

45630

1.30

49.09

2.7

2.6

61.09

65.86

u/l

0.82

5051

41977

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

957

5789

1.69

48.48

3.2

2.3

462.14

622.04

ug/l

1.07

926

5491

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

452

2151

2.13

48.23

2.1

2.2

32.37

32.76

1.02

446

2134

(3015736) pH of Urine

6271

53442

1.28

46.71

3.7

3.6

5.73

5.77

0.34

247

2486

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1378

9213

1.54

46.05

1.5

—

(3012441) Differential panel - Pleural fluid

409

1907

2.17

46.00

1.6

1.5

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

185

590

3.15

45.33

2.0

2.1

85.08

95.20

3.42

179

561

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5951

50676

1.27

43.69

4.5

4.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

438

2139

2.07

43.67

1.7

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4301

35167

1.30

43.58

2.9

2.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

188

621

3.04

43.41

15.0

3.6

1833.55

1145.49

mg/l

0.21

160

423

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

148

5.55

43.09

1.4

1.2

99.50

116.32

ug/l

0.40

(3012516) Albumin [Mass/volume] in Urine

5660

48028

1.27

42.43

3.2

3.3

296.96

406.99

mg/l

1.33

3891

31335

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7214

63071

1.25

41.58

2.2

2.1

92.11

93.60

pmol/l

1.97

4060

33460

(3020891) Body temperature

1027

6575

1.60

41.40

5.0

4.9

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

4364

35961

1.29

41.16

1.6

1.7

1.36

1.35

mmol/l

0.32

3446

29577

(3017143) Hepatitis C virus Ab [Presence] in Serum

1606

11328

1.46

41.10

1.6

—

(3004451) EKG impression Narrative

221

828

2.69

40.47

1.4

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

5725

48845

1.26

40.42

3.1

3.2

7.35

7.60

mmol/l

4.43

4731

40348

(3020682) Albumin/Creatinine [Ratio] in Urine

5921

50726

1.26

40.32

3.8

3.9

10.36

9.52

mg/mmol

0.45

3900

32526

(3000012) Reticulocyte production index

485

2530

1.94

40.17

2.2

—

(3037522) Nuclear Ab [Titer] in Serum

2128

15857

1.39

39.98

1.3

394.44

515.76

titre

3.76

432

3419

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1137

7522

1.55

39.67

4.9

4.1

48.06

47.51

0.33

1124

7431

(3045788) Cell count panel - Pleural fluid

361

1701

2.14

39.56

1.7

1.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1856

13576

1.41

38.80

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

786

4811

1.66

37.94

2.2

2.3

0.01

0.04

g/l

2.02

715

4365

(3021901) Oxygen saturation in Capillary blood

560

3147

1.80

36.73

3.2

2.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1628

11745

1.43

36.68

1.5

—

(3042733) HLA Ab [Presence] in Serum

132

391

3.39

36.56

5.0

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

209

803

2.62

36.45

1.4

14.74

13.97

umol/l

0.82

198

753

(3023199) Leukocytes [#/volume] in Pleural fluid

431

2236

1.95

36.30

1.6

1.5

1571.36

3058.33

e6/l

1.78

307

1634

(3028626) Oxygen [Partial pressure] in Capillary blood

635

3721

1.73

36.04

3.6

3.0

7.89

7.94

kpa

0.32

617

3641

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

617

3589

1.74

35.95

1.7

1.6

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

736

4497

1.66

35.76

2.2

2.4

0.00

g/l

0.17

667

4065

(3015377) Calcium [Moles/volume] in Serum or Plasma

5668

48805

1.24

35.57

3.3

3.5

2.34

2.35

mmol/l

6.15

5013

42088

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

724

4422

1.66

35.22

2.2

2.4

0.00

g/l

-0.00

664

4052

(3007164) IgA [Mass/volume] in Serum or Plasma

2709

21324

1.32

35.14

1.6

1.5

2.88

2.70

g/l

3.53

1582

12330

(3049717) Cytology report of Urine Cyto stain

1095

7379

1.51

34.97

2.5

2.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

630

3722

1.72

34.72

1.7

1.6

—

(40768806) Pleura Pathology biopsy report

383

1939

1.99

34.63

1.7

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

867

5569

1.58

34.36

2.4

2.5

0.72

1.08

g/l

2.46

742

4693

(3009445) Proteinase 3 Ab [Units/volume] in Serum

990

6553

1.54

34.35

1.4

1.5

9.67

17.34

u/ml

1.54

166

(3028308) Erythrocytes [#/volume] in Pleural fluid

396

2035

1.96

34.30

1.6

1.5

61644.21

59316.20

e6/l

0.06

238

1233

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

552

3154

1.77

34.23

1.7

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

338

1660

2.05

33.26

1.5

1.4

6.49

6.30

mmol/l

0.64

317

1529

(3026250) Tacrolimus [Mass/volume] in Blood

154

531

2.91

33.07

37.6

33.0

7.57

7.16

ug/l

1.44

140

466

(4094501) Cardiovascular stress test using bicycle ergometer

635

3816

1.69

32.86

1.1

—

(3051651) Icteric interference index of Serum or Plasma

215

881

2.45

32.82

5.0

3.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

280

1289

2.19

32.62

1.6

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

589

3479

1.71

32.49

2.2

1.8

11.83

11.72

mg/l

0.07

532

3223

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

490

2749

1.80

32.34

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1073

7350

1.49

31.58

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1594

11756

1.39

31.37

2.3

2.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1528

11202

1.40

31.15

1.6

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1117

7737

1.47

31.08

2.0

1.9

1.21

1.40

g/l

1.90

1029

6938

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

674

4203

1.63

30.19

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

865

5722

1.54

30.05

3.0

3.3

48.30

47.56

mg/l

0.03

660

4681

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

513

2993

1.73

29.60

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

476

2724

1.77

29.39

1.6

1.4

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1161

8190

1.45

29.33

4.1

3.6

25.37

25.12

mmol/l

1.86

1131

7956

(3034860) Kappa light chains.free [Mass/volume] in Serum

862

5730

1.53

29.27

3.0

3.3

64.60

67.67

mg/l

0.09

655

4685

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

105

312

3.37

29.04

2.0

220.99

202.23

0.97

100

296

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

622

3844

1.64

28.89

3.2

2.9

1.89

1.68

mg/l

7.21

567

3456

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

840

5575

1.53

28.73

3.0

3.3

2.50

4.68

ratio

0.71

415

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1439

10584

1.39

28.68

7.4

7.2

24.43

24.59

mmol/l

0.91

1378

10076

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

124

411

3.03

28.63

1.9

188.80

172.41

1.13

116

379

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

464

2657

1.76

28.60

1.3

33.14

40.33

u/l

0.83

419

2273

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1574

11754

1.37

28.58

3.4

2.8

55.32

61.48

ml/min/173m2

9.44

700

4836

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

779

5091

1.55

28.58

2.2

36.19

37.34

g/l

5.90

697

4338

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

417

2314

1.82

28.57

7.0

6.2

11.52

11.96

mg/l

1.31

388

2108

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3375

27987

1.26

28.27

3.0

3.3

2.46

mmol/l

0.92

2863

24489

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

829

5506

1.53

28.25

2.0

1.8

37.06

38.53

u/l

1.11

676

4746

(3005719) IgG [Mass/volume] in Serum or Plasma

1352

9882

1.40

27.94

2.7

2.8

10.83

10.67

g/l

0.61

1235

9004

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

396

2180

1.83

27.85

1.6

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

488

2859

1.72

27.75

8.4

5.0

538.29

1541.48

iu/ml

0.94

440

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

880

5948

1.50

27.60

2.6

2.8

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

330

1719

1.93

27.55

1.4

1.3

352.18

530.72

u/l

1.12

314

1634

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1543

11557

1.37

27.45

2.1

2.4

366.64

378.79

nmol/l

1.32

1446

10562

(1761868) Lipid panel - Serum or Plasma

4630

39831

1.22

27.44

3.5

3.2

—

(3021788) Differential panel - Synovial fluid

473

2761

1.73

27.26

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

275

1351

2.05

27.12

1.3

9.72

14.74

u/l

7.10

257

1245

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1014

7078

1.46

27.04

2.0

2.18

2.13

ug/l

0.05

898

6205

(3042631) Mycobacterium sp identified in Specimen

422

2392

1.78

26.95

2.7

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

670

4312

1.57

26.30

3.5

3.1

24.85

24.71

mmol/l

0.36

651

4225

(3018405) Lactate [Moles/volume] in Arterial blood

858

5892

1.48

24.86

4.4

4.2

1.40

1.39

mmol/l

0.02

840

5784

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

755

5053

1.51

24.82

1.7

1.6

245.00

264.67

titre

0.07

227

(3023183) Ammonium ion [Moles/volume] in Plasma

549

3424

1.62

24.60

2.5

31.93

33.70

umol/l

1.21

488

3055

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2878

23760

1.25

24.60

1.3

1.2

1.81

1.88

u/ml

0.10

778

5858

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

887

6156

1.46

24.35

2.2

2.4

3.16

2.95

g/l

7.12

804

5425

(40768804) Tissue Pathology biopsy report

6055

53893

1.19

24.24

2.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

149

4.23

24.21

2.5

2.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

152

615

2.48

23.99

29.6

28.7

124.11

111.72

ug/l

1.35

105

528

(3051611) Lipemic interference index of Serum or Plasma

305

1622

1.89

23.98

4.3

3.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1351

10121

1.36

23.88

3.9

3.7

2.11

1.76

mmol/l

2.78

990

7477

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

940

6620

1.44

23.88

2.1

2.3

7.24

7.47

g/l

3.97

859

5884

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

939

6614

1.44

23.83

2.1

2.3

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

937

6602

1.44

23.74

2.1

2.3

3.85

3.74

g/l

1.31

851

5876

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

191

3.77

23.68

1.3

1.2

82.35

81.58

0.06

(40768797) Stomach Pathology biopsy report

2392

19404

1.27

23.66

1.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

7.80

23.30

4.1

14.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

370

2108

1.77

23.27

1.5

1.4

129.25

115.15

u/ml

0.63

467

(3022145) Colonoscopy Study observation

1986

15784

1.29

23.11

1.4

1.3

—

(3035880) pH of Pleural fluid

213

1011

2.12

23.10

1.4

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1497

11453

1.33

22.99

4.3

3.9

113.58

97.16

ng/l

7.67

1284

9737

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

882

6194

1.44

22.74

2.1

2.3

10.42

10.24

g/l

0.64

794

5406

(40760888) Immunoglobulin light chains.free panel - Serum

646

4276

1.53

22.37

3.2

3.4

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

7.02

21.94

1.3

1.4

159.11

131.67

ug/l

0.23

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

635

4207

1.53

21.90

1.4

1.5

16.12

15.62

iu/ml

0.03

(3051593) INR in Capillary blood by Coagulation assay

189

876

2.17

21.82

22.4

8.9

—

(3009343) pH of Capillary blood

1378

10497

1.34

21.76

4.0

3.7

7.42

0.06

286

1304

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

195

916

2.14

21.76

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

195

916

2.14

21.76

1.6

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

301

1647

1.84

21.69

3.5

3.6

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

976

7042

1.41

21.64

5.4

5.2

1.61

1.64

0.39

916

6612

(3035947) Staphylolysin Ab [Units/volume] in Serum

164

721

2.28

21.54

1.2

1.1

3.14

4.17

iu/ml

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2406

19746

1.25

21.35

1.3

37.74

40.14

iu/ml

0.32

711

6122

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1390

10636

1.33

21.27

4.0

3.7

5.15

5.13

kpa

0.36

1315

10019

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

366

2154

1.71

20.57

1.5

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

832

5888

1.43

20.57

1.2

115.16

126.20

iu/ml

0.33

251

1994

(3038071) Oxygen [Partial pressure] in Mixed venous blood

100

355

2.82

20.55

5.8

8.0

—

(3003338) MCHC [Mass/volume]

11245

106176

1.18

20.54

33.3

22.0

331.15

332.40

g/l

37.59

11147

105303

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

400

2417

1.67

20.37

1.5

1.4

—

(3000494) Fungus identified in Specimen by Culture

2021

16335

1.27

20.37

1.6

1.5

—

(3002256) Pathology report gross observation

2263

18545

1.25

20.25

1.4

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

397

2399

1.67

20.22

1.5

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

211

1059

2.00

19.76

1.5

1.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

291

1625

1.80

19.66

1.4

1.2

6.22

3.71

u/ml

0.77

121

550

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

193

3.47

19.58

1.3

1.2

73.47

73.13

0.02

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6005

54099

1.17

19.43

2.3

2.2

77.61

78.72

nmol/l

2.28

5310

47293

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

399

2443

1.65

19.33

3.6

3.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

947

6937

1.38

19.18

5.5

5.2

0.84

0.88

3.49

888

6514

(3011397) Hemoglobin [Presence] in Urine by Test strip

3746

32479

1.20

19.05

3.8

—

(3019309) Folate [Moles/volume] in Red Blood Cells

3624

31328

1.20

19.04

1.9

1.8

1221.94

1150.72

nmol/l

4.21

2783

23275

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

290

1638

1.78

18.88

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

109

423

2.58

18.88

6.0

8.1

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

271

1500

1.82

18.87

1.2

54.22

66.34

u/l

2.22

234

1334

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

284

1596

1.79

18.81

1.4

1.2

4.34

3.70

u/ml

0.49

147

719

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

141

617

2.29

18.79

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

383

2341

1.65

18.69

1.5

1.4

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

170

812

2.10

18.25

1.2

1.3

25.37

26.85

u/l

0.22

147

683

(3009871) Measles virus Ab [Titer] in Serum

296

2.87

18.15

1.4

1.7

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

587

3991

1.48

17.92

1.5

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

362

2206

1.65

17.90

3.3

2.6

1010.96

5443.04

u/ml

0.63

149

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1521

18907

0.78

17.77

5.0

4.9

32.69

32.61

0.11

1187

12524

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

5.71

17.48

2.5

2.2

1.87

2.13

mg/l

0.39

(3035320) C reactive protein [Mass/volume] in Body fluid

189

954

1.99

17.48

3.0

2.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

549

3703

1.50

17.44

1.7

1.5

1.17

1.18

g/l

0.28

527

3495

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

174

3.45

17.40

1.2

7.25

186023.02

nmol/l

0.72

143

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

171

835

2.05

17.34

1.2

1.3

108.25

94.81

u/l

0.58

151

718

(3034770) Mitochondria Ab [Titer] in Serum

498

3296

1.52

17.32

1.2

561.43

940.97

titre

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

239

1311

1.83

17.19

1.5

1.4

14.49

12.78

u/l

2.57

232

1260

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

533

3590

1.50

17.05

1.7

1.5

0.24

g/l

0.11

510

3374

(3000475) Leukocytes [#/volume] in Synovial fluid

555

3774

1.48

16.94

1.7

1.6

22174.06

14623.14

e6/l

1.43

397

2732

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

257

1448

1.78

16.93

1.5

23.02

27.75

1.76

177

909

(3024932) HLA-DR beta [Type]

101

399

2.53

16.91

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1579

12677

1.27

16.66

1.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

328

1991

1.66

16.50

1.3

1.2

312.18

283.97

u/ml

0.94

229

1223

(3024471) HLA-A [Type]

102

410

2.49

16.48

1.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

198

1042

1.91

16.24

1.2

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

4553

40596

1.16

16.00

3.2

0.76

0.79

ug/l

0.81

3216

28427

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

140

655

2.14

15.93

1.5

1.4

65.36

61.97

0.53

112

535

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

128

578

2.22

15.91

2.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

280

1650

1.70

15.78

1.8

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

280

1651

1.70

15.74

1.8

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

211

1146

1.85

15.71

1.3

1.1

87.56

95.99

3.73

203

1057

(3019225) pH of Specimen

1268

15887

0.78

15.69

4.7

4.5

—

(3025941) Bacteria identified in Stool by Culture

900

6759

1.35

15.57

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

492

3326

1.49

15.50

1.2

112.97

119.03

titre

0.09

277

(3043409) Potassium [Moles/volume] in Arterial blood

700

5059

1.40

15.39

4.8

4.4

3.98

3.91

mmol/l

3.05

693

5018

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1606

13039

1.25

15.36

1.8

1.58

0.01

1342

11055

(3048929) Epstein Barr virus Ab [Presence] in Serum

414

2710

1.54

15.20

1.3

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

167

851

1.97

15.10

3.5

3.8

—

(3040151) Glucose [Moles/volume] in Capillary blood

308

1884

1.64

15.08

6.3

10.8

7.46

7.47

mmol/l

0.03

258

1535

(3017569) Oxygen content in Arterial blood

155

770

2.02

15.06

2.4

2.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

255

1490

1.72

14.85

1.3

1.1

95.15

116.23

15.38

234

1328

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

327

2047

1.61

14.60

1.1

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

121

554

2.19

14.58

1.5

1.4

1.97

3.14

0.89

101

462

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

190

1030

1.85

14.28

2.4

2.3

—

(3033799) Differential panel - Peritoneal fluid

111

495

2.25

14.27

2.1

1.9

—

(3023419) Bacteria identified in Sputum by Culture

389

2549

1.54

14.24

2.3

2.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

193

1056

1.83

14.09

2.7

2.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

336

2140

1.58

13.97

1.3

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

366

2378

1.55

13.94

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2175

18427

1.20

13.72

1.3

1.2

17.54

14.97

u/ml

0.32

798

6430

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

185

1008

1.84

13.70

1.2

1.1

—

(40763791) Oxygen content in Venous blood by calculation

6.46

13.58

7.6

3.6

11.31

11.99

ml/dl

0.25

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

343

2215

1.56

13.44

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

277

1701

1.64

13.41

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

296

1852

1.61

13.29

1.3

0.26

0.29

nmol/l

0.11

163

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

138

691

2.00

13.18

1.8

2.0

389.89

943.24

u/l

0.54

206

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

295

1853

1.60

13.04

1.3

0.70

2.17

nmol/l

1.03

279

1769

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

186

1044

1.79

12.55

1.1

1.2

158.75

154.14

titre

0.03

191

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

262

1622

1.62

12.32

1.2

1.3

—

nmol/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

153

813

1.89

12.32

1.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

153

814

1.88

12.27

1.3

1.5

—

(3034426) Prothrombin time (PT)

368

2.34

12.24

1.4

1.2

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

637

4711

1.36

12.22

1.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

106

496

2.14

12.18

1.3

1.4

18.48

22.09

0.75

440

(3011985) Renin [Units/volume] in Plasma

286

1815

1.58

12.14

1.3

1.4

71.84

60.52

mu/l

0.41

251

1601

(1002224) Polysomnography panel

545

3942

1.39

12.00

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

203

1187

1.71

11.90

1.2

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

251

1553

1.62

11.85

1.3

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

271

2.55

11.84

1.5

10.97

10.29

0.09

135

(3003694) ABO and Rh group [Type] in Blood

3857

34594

1.15

11.80

1.4

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

261

2.57

11.69

1.3

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

287

2.47

11.48

1.2

80.63

98.55

2.45

266

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7612

71362

1.12

11.25

5.1

5.3

2.86

3.51

ug/l

1.89

6744

63738

(3015171) Extractable nuclear Ab [Units/volume] in Serum

586

4341

1.36

11.16

1.2

0.39

0.94

u/ml

1.86

424

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

299

1960

1.53

11.04

1.6

1.5

66.10

60.95

1.62

212

1238

(40762365) Oxygen content in Arterial blood by calculation

294

2.42

10.92

2.8

3.1

14.85

14.65

ml/dl

0.23

275

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

137

3.14

10.87

1.2

1.1

11.68

20.38

iu/ml

0.69

(3020961) Endomysium IgA Ab [Titer] in Serum

608

4551

1.35

10.83

1.1

149.31

231.04

titre

0.56

112

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

264

1693

1.56

10.77

1.3

331.75

349.38

pmol/l

0.10

227

1420

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

4.17

10.74

1.4

1.1

3232.33

2076.83

ng/l

0.79

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

219

1346

1.63

10.67

1.2

—

38.71

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

157

882

1.78

10.64

1.7

1.6

6.40

7.10

u/l

0.22

113

704

(3037756) Immunofixation for Serum or Plasma

519

3804

1.37

10.59

1.5

1.6

—

(3014891) Appearance of Pleural fluid

252

2.50

10.46

1.4

1.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

203

1233

1.65

10.38

2.0

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

153

861

1.78

10.32

1.9

2.1

18.07

32.28

umol/l

1.00

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

142

3.03

10.26

1.3

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

285

2.39

10.22

1.1

68.98

83.64

2.31

145

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

356

2469

1.45

10.00

1.7

1.6

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

356

2469

1.45

10.00

1.7

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

497

3655

1.37

9.95

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

497

3665

1.36

9.79

1.2

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

174

2.76

9.71

1.1

19.46

18.86

u/l

0.08

119

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

491

3621

1.36

9.67

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

281

2.35

9.60

1.1

1.2

62.45

83.06

2.92

146

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3604

32556

1.13

9.59

1.8

1.7

32166589.40

29455015.92

pmol/l

0.10

2913

26237

(3019977) pH of Arterial blood

163

958

1.70

9.48

2.3

2.5

7.43

7.42

0.91

327

(3002331) Protein [Mass/volume] in Peritoneal fluid

362

2.15

9.26

1.4

32.65

45.27

g/l

0.35

278

(3026692) Albumin [Mass/volume] in Peritoneal fluid

416

2.07

9.18

1.9

1.4

17.62

13.08

g/l

5.14

312

(3024263) Appearance of Synovial fluid

140

799

1.75

9.07

1.4

1.3

—

(3044242) Glucose [Moles/volume] in Arterial blood

142

814

1.75

9.06

2.3

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

495

3708

1.34

8.84

2.8

2.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.59

8.77

1.1

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

810

6495

1.26

8.64

1.3

268.00

276.03

u/ml

0.08

757

5952

(3008037) Lactate [Moles/volume] in Venous blood

507

3829

1.33

8.58

4.7

3.4

1.62

1.66

mmol/l

0.28

488

3745

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

127

717

1.77

8.56

1.1

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

290

2006

1.45

8.34

1.4

1.6

0.75

0.88

g/l

1.11

204

1499

(3016650) Hepatitis A virus Ab [Presence] in Serum

276

1894

1.46

8.28

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

363

2.07

8.05

1.6

1.4

17.54

16.27

pmol/l

0.44

287

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

17.11

8.05

1.1

1.3

—

(3003181) Sodium [Moles/volume] in Urine

388

2843

1.37

8.04

1.3

61.92

62.61

mmol/l

0.12

315

2279

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

194

2.47

7.89

2.4

2.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

393

2896

1.36

7.87

1.6

1.5

—

(3048689) Calprotectin [Mass/mass] in Stool

1526

13142

1.17

7.83

2.1

2.2

149.51

163.72

ug/g

0.71

1187

10286

(3045716) Anion gap in Serum or Plasma

126

735

1.72

7.63

2.8

2.2

9.38

9.76

mmol/l

0.67

121

716

(3034891) Synovial lining cells/100 cells in Synovial fluid

123

714

1.72

7.59

1.5

2.97

3.80

0.37

157

(44786800) Granulocytes/100 leukocytes in Body fluid

235

2.30

7.56

1.4

1.3

20.69

25.30

0.49

188

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

314

2250

1.40

7.48

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

181

1164

1.56

7.45

1.7

1.4

39.71

26.66

iu/ml

0.37

(3037692) Legionella sp identified in Specimen by Organism specific culture

102

564

1.81

7.44

1.7

1.4

—

(3018572) Chloride [Moles/volume] in Blood

491

3778

1.31

7.34

6.9

7.0

105.36

104.98

mmol/l

1.12

447

3405

(3039000) Anion gap in Blood

491

3778

1.31

7.34

6.9

7.0

11.38

11.23

mmol/l

0.44

447

3405

(40768443) Skin Pathology biopsy report

784

6400

1.23

7.17

1.2

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

190

1248

1.52

7.13

1.3

1.4

7.52

7.01

g/l

0.65

115

856

(4062490) Immunoglobulin typing, IgG

190

1250

1.52

7.08

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

506

3932

1.29

7.04

1.4

1.5

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

189

1248

1.52

6.93

1.3

1.4

0.44

g/l

0.03

113

861

(3028192) IgG subclass 2 [Mass/volume] in Serum

189

1249

1.52

6.91

1.3

1.4

2.78

2.96

g/l

0.60

113

860

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

294

2.07

6.70

6.5

7.1

—

(3047181) Lactate [Moles/volume] in Blood

652

5262

1.25

6.65

6.2

6.1

1.37

1.34

mmol/l

0.35

569

4671

(3000093) Morphology [Interpretation] in Blood Narrative

231

1603

1.44

6.63

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

1148

0.50

6.60

1.0

250.17

330.45

ng/l

3.43

785

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

229

3239

0.70

6.59

1.3

563.75

589.39

mg/l

0.30

218

3071

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

385

1.92

6.57

1.1

—

(4200892) Spirometry reversibility

1228

10545

1.17

6.54

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

1152

0.51

6.45

1.0

32.48

42.71

ng/l

2.48

773

(3033705) Calcium.ionized [Moles/volume] in Venous blood

302

2208

1.37

6.44

3.4

2.4

—

(3023383) Lactate [Moles/volume] in Pleural fluid

101

583

1.73

6.43

1.4

1.3

2.96

3.56

mmol/l

1.45

539

(3041918) Cholesterol [Moles/volume] in Pleural fluid

340

1.97

6.41

1.3

1.2

1.32

1.54

mmol/l

1.18

208

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

1149

0.51

6.41

1.0

735.66

714.94

ng/l

0.11

756

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

334

1.98

6.36

1.1

1.2

549.59

276.85

pmol/l

0.60

243

(3012565) Volume of 24 hour Urine

124

759

1.63

6.35

2.2

2.3

1846.62

1921.76

0.36

105

651

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

6030

56932

1.09

6.34

4.5

22.11

22.07

0.07

2996

29435

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

246

1743

1.41

6.32

1.1

1.60

1.55

g/l

1.30

237

1550

(3038515) Glucose [Moles/volume] in Venous blood

467

3647

1.29

6.30

5.0

3.5

7.39

7.74

mmol/l

2.71

451

3573

(3000285) Sodium [Moles/volume] in Blood

210

2.24

6.26

1.2

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

415

1.85

6.17

1.1

1.2

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

509

1.77

6.17

1.5

1.6

3.29

9.85

nmol/l

0.80

441

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

546

1.74

6.16

1.3

115.09

316.35

ug/l

1.16

294

(36660697) Celiac disease serology panel - Serum

1016

8648

1.18

6.03

1.2

—

(4035726) Immunohistochemistry procedure

1478

12968

1.15

5.94

1.5

1.4

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

371

1.89

5.93

1.1

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

560

4512

1.25

5.84

1.1

41.69

5.51

u/ml

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1535

13524

1.15

5.82

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

988

8422

1.18

5.78

2.4

2.5

—

(3011544) Albumin [Mass/volume] in Pleural fluid

173

2.31

5.77

1.3

1.2

13.89

17.84

g/l

2.93

155

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

506

1.74

5.73

2.3

1.8

14463.61

13432.50

e6/l

0.06

287

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

143

2.44

5.72

3.1

2.2

66.00

57.08

0.75

(3004716) Salmonella sp identified in Stool by Organism specific culture

573

4643

1.24

5.69

1.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

569

1.69

5.61

1.1

1.2

188.21

166.97

mmol/24h

0.93

569

(3002621) Streptococcal DNAse B [Units/volume] in Serum

115

2.61

5.59

1.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

100

600

1.67

5.59

2.4

2.6

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

316

2382

1.33

5.58

1.1

1.2

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

113

700

1.61

5.57

2.4

2.8

222.60

206.38

u/l

1.18

113

692

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

337

1.90

5.55

2.8

2.4

6.87

7.89

mmol/l

1.47

217

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

223

1593

1.40

5.53

1.2

216.73

203.58

miu/ml

0.17

490

(3001964) Herpes simplex virus Ag [Presence] in Specimen

380

1.84

5.53

1.7

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

131

843

1.55

5.51

2.2

67.57

134.20

ug/min

0.98

205

(4281824) Cell count and differential, peritoneal fluid

176

1207

1.46

5.46

1.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

582

1.67

5.43

2.3

2.0

10862.66

3737.16

e6/l

0.38

415

(3006576) Bicarbonate [Moles/volume] in Blood

102

621

1.64

5.40

6.5

24.64

25.07

mmol/l

0.48

553

(44816559) Phosphatidylethanol [Mass/volume] in Blood

275

2043

1.35

5.37

1.3

—

(3045414) Leukocytes [Presence] in Urine

738

6181

1.20

5.30

2.1

1.9

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

490

1.71

5.24

1.4

1.3

65.03

59.04

0.89

416

(3044007) Cell count panel - Peritoneal fluid

453

1.74

5.23

1.8

1.9

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

264

1969

1.34

5.05

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

207

2836

0.72

5.03

1.3

1.2

3.81

3.90

mmol/l

0.72

192

2661

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

208

1496

1.39

5.00

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

350

1.83

4.98

1.3

1.4

104.64

265.01

nmol/24h

0.91

350

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

460

3703

1.25

4.91

1.5

1.6

0.26

6.43

iu/ml

2.02

105

872

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

115

741

1.55

4.86

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

115

742

1.55

4.83

1.1

1.0

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

126

830

1.52

4.82

1.9

—

(3003327) Ova and parasites identified in Stool by Light microscopy

443

3570

1.24

4.70

1.6

1.7

—

(3008536) Aspergillus sp Ab [Presence] in Serum

300

1.87

4.67

1.5

2.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

209

1525

1.37

4.64

1.4

273787.05

134963.02

e6/l

1.15

152

1044

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.10

4.61

1.7

1.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

104

2.50

4.50

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

241

1.95

4.48

12.3

10.7

5.77

5.52

mmol/l

0.16

241

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

194

2.06

4.45

4.6

5.2

66.89

54.17

ug/min

0.39

166

(3020491) Glucose [Moles/volume] in Blood

148

1026

1.44

4.43

2.1

1.9

7.29

7.28

mmol/l

0.03

113

688

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

147

1019

1.44

4.40

1.2

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

210

2.00

4.31

1.5

1.4

77.18

70.24

0.90

173

(3022313) Gas panel - Capillary blood

885

7666

1.16

4.31

4.2

3.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

119

799

1.49

4.21

1.1

—

(3047189) Immunofixation for 24 hour Urine

124

840

1.48

4.20

1.6

1.7

—

(21494755) Public health laboratory ask at order entry panel

539

6399

0.83

4.09

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

131

903

1.45

4.08

2.0

1.9

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

212

2790

0.75

4.02

1.5

1.4

1413.00

2229.14

e6/l

0.37

170

2286

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

186

1368

1.36

4.00

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

212

2786

0.76

3.98

1.5

1.4

92.32

28.36

e6/l

0.52

157

2168

(3042010) Triglyceride [Moles/volume] in Pleural fluid

252

1.86

3.97

1.4

1.3

0.76

1.17

mmol/l

0.42

159

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

625

7301

0.85

3.94

1.8

1.9

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

311

1.77

3.92

2.8

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

462

1.62

3.91

1.2

0.12

0.71

g/l

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

326

1.75

3.91

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

439

3616

1.22

3.86

1.9

1.6

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

449

1.62

3.84

1.2

1.1

7.22

10.53

u/ml

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

2.83

3.76

1.7

1.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

114

2.28

3.74

3.4

2.1

9.70

16.28

0.74

(3044290) Cell count panel - Cerebral spinal fluid

197

2587

0.76

3.71

1.4

1.3

—

(3035510) Gentamicin [Mass/volume] in Serum or Plasma

2.90

3.71

3.1

7.0

0.92

1.02

mg/l

0.20

(3046861) Legionella sp Ag [Presence] in Urine

2.44

3.68

1.2

1.0

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

223

1.88

3.68

1.3

1.2

59.54

518.53

ng/l

0.68

147

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

2.53

3.60

1.1

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

249

1942

1.28

3.58

1.8

2.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

215

1647

1.31

3.55

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

116

806

1.44

3.52

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

116

806

1.44

3.52

1.2

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

507

1.56

3.51

2.7

2.0

51.18

58.93

ug/l

0.44

494

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

322

1.71

3.51

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

398

3281

1.22

3.51

1.2

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

308

1.72

3.48

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

580

1.52

3.48

1.1

1.10

1.08

ratio

0.41

179

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

116

811

1.43

3.42

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

116

812

1.43

3.40

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

115

805

1.43

3.37

1.2

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

305

1.70

3.32

1.2

139.98

69.64

mu/l

0.89

222

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

777

0.59

3.26

1.2

1.1

44.19

46.19

mg/l

0.16

662

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

115

811

1.42

3.25

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

180

1366

1.32

3.22

1.1

1.2

60.08

50.04

u/ml

0.15

(4146454) Self-monitoring of blood glucose

149

1987

0.75

3.19

2.8

2.7

—

(3000330) Specific gravity of Urine by Test strip

895

7936

1.13

3.19

3.8

—

(3045142) Bone marrow Pathology biopsy report

239

1889

1.27

3.14

1.3

—

(3016038) Potassium [Moles/volume] in Urine

141

1037

1.36

3.12

1.1

37.33

34.75

mmol/l

0.61

120

866

(3020876) Protein [Mass/time] in 24 hour Urine

247

1965

1.26

3.08

2.2

2.4

1.12

1.27

g/24h

0.37

122

963

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1406

12830

1.10

3.00

2.2

2.1

12.71

12.49

nmol/l

0.40

1216

11282

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

732

0.60

2.98

1.1

280.14

324.99

mg/l

1.47

647

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.34

2.96

1.5

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

407

0.47

2.95

1.1

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

255

2051

1.24

2.91

1.8

433.32

288.24

mu/l

0.49

238

1904

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

235

1.74

2.88

1.2

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

469

1.51

2.85

1.3

1.2

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

214

1.77

2.84

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

127

936

1.36

2.82

1.9

14.99

16.97

1.46

122

905

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

744

6585

1.13

2.77

4.4

4.1

24.92

24.81

mmol/l

0.46

682

6026

(1175426) CD3 cells/100 lymphocytes in Blood

129

958

1.35

2.74

1.9

71.32

70.15

0.32

122

907

(3000060) B lymphocytes [#/volume] in Blood

241

1.70

2.66

1.7

2.0

1762.59

2260.98

e6/l

0.11

122

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1257

0.71

2.66

1.0

1.1

—

27.03

—

(3036603) Volume of Urine

135

1015

1.33

2.65

1.5

1.6

1939.12

1863.44

0.45

130

973

(3019174) dRVVT (LA screen)

2.17

2.65

1.3

1.2

—

(3025577) Chromium [Mass/volume] in Blood

153

1172

1.31

2.63

2.0

1.97

2.18

ug/l

0.39

134

966

(3034274) Bile acid [Moles/volume] in Serum --fasting

503

1.47

2.62

1.4

1.5

8.88

14.77

umol/l

1.41

353

(3016750) Collection duration of Urine

137

1035

1.32

2.61

2.2

2.1

492.69

498.73

min

0.27

748

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

125

932

1.34

2.60

1.1

1.2

—

(3008295) Osmolality of Serum or Plasma

191

1509

1.27

2.59

1.3

275.94

277.59

mosm/kgh2o

0.35

145

1160

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

692

0.62

2.59

1.1

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.25

2.58

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

325

2717

1.20

2.58

1.3

—

(3013727) Leukocytes other/100 leukocytes in Blood

521

1.46

2.58

2.6

3.9

55.16

53.89

0.22

504

(3010838) Calcium [Moles/time] in 24 hour Urine

274

2255

1.22

2.57

1.8

4.83

4.84

mmol/24h

0.01

246

1924

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

238

1.68

2.51

1.5

1.3

49.96

355.38

u/l

0.88

167

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

108

2.03

2.49

1.5

1.6

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

308

1.59

2.48

1.8

1.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

356

1.54

2.47

1.1

—

(3016330) Potassium [Moles/time] in 24 hour Urine

180

1.77

2.44

1.3

1.2

—

82.23

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

668

5927

1.13

2.44

2.9

3.4

1071.37

1834.01

u/ml

0.49

556

5129

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.08

2.40

1.3

1.1

—

(21494434) Karyotype in Bone marrow

189

1510

1.25

2.37

1.1

1.2

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

391

4526

0.86

2.34

1.5

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

466

1.46

2.34

1.4

17.65

23.03

1.08

392

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.04

2.29

1.3

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

154

1207

1.28

2.28

2.0

1.9

4.09

3.55

ug/l

0.28

146

1094

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

192

1.72

2.27

1.0

1.5

—

11.66

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

118

895

1.32

2.24

1.6

1.7

—

(3029075) Extractable nuclear Ab panel - Serum

325

1.54

2.23

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

120

1.91

2.23

1.3

1.1

—

(3002619) Bacteria identified in Specimen by Culture

294

1.56

2.21

1.3

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

253

2105

1.20

2.18

1.2

50.05

48.08

u/ml

0.04

215

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

199

1618

1.23

2.16

2.7

2.9

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

542

1.40

2.14

1.5

1.7

80.37

108.99

umol/l

0.97

285

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

547

0.62

2.11

1.0

1.1

0.92

1.08

u/l

3.31

268

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

349

2997

1.17

2.09

1.9

1.8

196.01

197.38

pmol/l

0.10

319

2796

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

182

1.70

2.09

3.7

4.9

—

(3015183) Erythrocyte sedimentation rate

372

1.48

2.06

1.1

1.3

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

260

1.57

2.06

1.7

1.9

7.78

8.51

mg/l

0.38

204

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

543

0.62

2.05

1.6

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

454

3980

1.14

2.05

1.5

1.6

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

292

1.54

2.05

1.0

1.1

0.63

0.68

umol/24h

0.42

131

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

154

1.75

2.01

1.5

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

101

763

1.32

2.01

1.1

89.38

91.16

u/l

0.08

684

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

155

1240

1.25

1.98

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

1042

0.74

1.97

1.0

1.1

—

(3017704) Immunofixation for Urine

126

985

1.28

1.95

1.4

1.5

—

(3011288) Drugs identified in Urine by Screen method

1017

0.73

1.94

2.3

2.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

105

803

1.31

1.93

1.9

2.72

2.81

u/field

0.03

549

(3020650) Glucose [Presence] in Urine

297

1.51

1.92

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

379

1.45

1.90

1.6

1.3

—

(40757373) Influenza virus identified in Isolate

330

1.48

1.90

1.9

1.6

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1838

19418

0.94

1.90

11.4

7.9

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

572

5117

1.12

1.89

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

290

1.51

1.89

1.7

1.2

194.11

230.42

titre

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

100

762

1.31

1.89

1.1

29.14

30.48

u/l

0.07

675

(3004809) Band form neutrophils/100 leukocytes in Blood

317

2732

1.16

1.85

3.1

3.5

1.33

1.56

0.55

291

2392

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

504

0.63

1.85

2.2

3.0

27.18

29.04

umol/l

0.49

383

(3000570) Elastase.pancreatic [Mass/mass] in Stool

496

4407

1.13

1.85

1.4

253.30

259.75

ug/g

0.31

302

2696

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

482

1.39

1.84

1.8

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

458

4051

1.13

1.84

1.7

44.75

43.56

nmol/l

0.54

447

3884

(3037121) Protein [Mass/volume] in Urine

600

5394

1.11

1.83

2.7

3.1

0.28

0.33

g/l

0.89

273

2449

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.20

1.82

1.0

1.2

1.29

1.41

u/field

—

(3021374) Sirolimus [Mass/volume] in Blood

4.16

1.82

5.6

10.0

9.10

6.94

ug/l

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

190

1.63

1.81

1.0

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

493

4392

1.12

1.77

1.5

1.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

102

1.86

1.74

1.5

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.89

1.73

1.3

0.05

0.07

g/l

1.25

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

412

1.41

1.73

1.2

1.1

1438.28

1590.50

miu/ml

0.51

412

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.49

1.73

6.3

9.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

1040

0.76

1.71

1.1

1.3

2.42

2.21

mmol/l

0.31

968

(3001729) Color of Synovial fluid

132

1.74

1.71

1.7

1.5

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

184

1526

1.21

1.71

1.6

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

107

1354

0.79

1.71

1.4

—

(40761535) Cells panel - Urine sediment

1389

13008

1.07

1.69

3.6

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

293

2532

1.16

1.68

1.4

9.44

9.13

u/l

0.15

232

2027

(3035611) Eosinophils/100 leukocytes in Synovial fluid

111

1.80

1.67

1.8

1.5

1.32

0.85

0.28

(3017354) Segmented neutrophils/100 leukocytes in Blood

143

1745

0.82

1.66

3.1

3.4

57.28

58.04

0.14

123

1444

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

114

903

1.26

1.64

1.0

2808.79

285.04

mg/l

0.50

106

806

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

3.56

1.61

1.2

1.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

747

1.28

1.60

1.3

0.51

1.48

u/ml

2.33

458

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

121

1.73

1.56

1.3

0.83

0.95

ml/s/173m2

—

(40768795) Lymph node Pathology biopsy report

168

1397

1.20

1.55

1.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

405

1.38

1.54

1.7

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

157

1881

0.83

1.54

3.9

4.5

346.42

347.78

umol/l

0.04

135

1572

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

126

1022

1.23

1.50

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.15

1.49

1.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

930

8633

1.08

1.48

3.1

2.9

0.29

e6/l

0.00

917

8491

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

217

1859

1.17

1.45

1.5

—

(3011412) CD3 cells [#/volume] in Blood

151

1255

1.20

1.43

2.2

0.92

1.10

e9/l

1.80

141

1144

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

2.72

1.43

5.2

3.9

—

(3004775) Volume in Urine collected for unspecified duration

174

1466

1.19

1.42

2.3

683.46

688.27

0.04

106

970

(3051387) C reactive protein [Mass/volume] in Capillary blood

360

3199

1.13

1.42

4.6

3.5

28.17

29.60

mg/l

0.29

234

2065

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

422

0.66

1.39

2.9

2.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

658

1.27

1.38

1.3

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.07

1.37

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

190

1619

1.17

1.37

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

471

4260

1.11

1.36

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

302

2663

1.13

1.36

1.1

—

(3018291) Platelet Ab [Presence] in Serum

2.60

1.36

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

330

1.39

1.36

1.1

1.2

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

544

0.71

1.30

1.0

1.1

147.00

625.62

ng/l

—

154

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

129

1.62

1.28

1.2

1.5

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

358

3204

1.12

1.28

3.3

1.6

4.97

3.97

mg/l

0.72

299

2384

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

525

1.29

1.27

2.2

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

525

1.29

1.27

2.2

2.4

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

211

1828

1.15

1.25

2.8

3.5

5.65

11.29

nmol/l

1.10

202

1783

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

469

4263

1.10

1.25

2.3

106.19

122.79

ug/min

0.43

279

2521

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

115

1.65

1.23

1.5

1.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

147

1241

1.18

1.22

1.5

1.6

30.38

26.61

u/ml

0.28

271

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.76

1.21

2.1

2.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

245

1.43

1.21

1.0

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

212

1.46

1.21

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

246

1.42

1.19

2.5

3.3

9.24

6.87

mg/l

1.13

204

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

764

1.23

1.17

1.8

1.5

5.63

6.37

u/l

0.74

639

(3002523) Influenza virus A Ag [Presence] in Specimen

130

1091

1.19

1.16

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.49

1.15

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1801

17224

1.05

1.13

3.5

4.1

10.22

26.40

ug/l

6.82

1445

14436

(3013139) Helicobacter pylori Ag [Presence] in Stool

874

8196

1.07

1.11

1.2

—

(40768793) Breast Pathology biopsy report

230

2027

1.13

1.10

1.3

—

(3017732) Neutrophils [#/volume] in Blood

865

9170

0.94

1.09

3.1

5.22

5.33

e9/l

0.09

707

6888

(3044927) Protein electrophoresis panel - Urine

209

1834

1.14

1.08

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

126

1064

1.18

1.07

1.2

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

165

1425

1.16

1.07

1.1

7.08

10.80

au/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

235

1.40

1.07

1.3

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

425

1.29

1.06

1.0

1.1

94.62

98.71

0.28

332

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

434

1.29

1.06

1.1

1.2

—

(3036525) Urea [Moles/time] in 24 hour Urine

105

1.62

1.05

2.1

3.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

559

1.25

1.04

1.8

1.9

—

(3012403) Metanephrines [Moles/time] in 24 hour Urine

2.27

1.03

1.0

1.1

—

26.24

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.05

1.02

1.0

—

(3023410) Appearance of Cerebral spinal fluid

101

1202

0.84

1.02

1.7

1.5

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

123

1044

1.18

1.01

1.3

495.56

418.94

titre

—

104

(3013466) aPTT in Blood by Coagulation assay

1.88

1.00

1.1

40.68

38.22

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

281

1.35

1.00

2.8

—

(3035933) Granulocytes/100 leukocytes in Blood

225

0.62

0.99

1.3

1.4

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

205

1.41

0.99

1.6

2.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

182

1595

1.14

0.98

1.3

1.4

21.53

30.55

iu/l

4.12

154

1327

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

343

1.31

0.97

2.1

2.2

1.04

1.03

ug/l

0.01

322

(3003740) Influenza virus B Ag [Presence] in Specimen

128

1094

1.17

0.97

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

132

1.51

0.95

1.0

1.2

1.92

1.77

umol/24h

0.32

132

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

119

1013

1.17

0.95

1.3

176.00

66.13

titre

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

594

5534

1.07

0.95

1.3

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

165

1.45

0.95

1.7

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

116

1353

0.85

0.94

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

745

0.80

0.94

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

756

0.80

0.94

1.4

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

749

1.20

0.93

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

613

1.22

0.93

1.2

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

713

1.20

0.93

6.0

6.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

605

1.22

0.92

1.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

1047

0.84

0.91

1.2

3.00

3.36

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1101

0.84

0.91

1.2

18.42

42.68

u/ml

1.63

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

2.14

0.91

1.3

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

102

0.49

0.89

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

344

3146

1.09

0.89

1.2

54.24

42.56

u/ml

0.25

168

(3042951) Complement C1q Ab [Units/volume] in Serum

1.90

0.88

1.3

1.1

—

15.74

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

411

1.26

0.88

1.3

37.70

32.44

0.49

266

(1761482) Bacteria [#/volume] in Urine by Culture

423

4551

0.93

0.86

4.7

4.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

390

0.74

0.85

2.2

2.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.81

0.85

1.1

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

691

0.81

0.85

1.1

1.3

25.63

28.34

u/l

0.23

555

(3038026) Centromere Ab [Units/volume] in Serum

1124

0.85

0.84

1.2

54.04

45.85

u/ml

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

576

1.21

0.84

1.2

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

759

1.18

0.83

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.62

0.83

1.5

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

229

2064

1.11

0.82

2.4

2.6

59.36

741.16

u/ml

2.92

219

2033

(3008898) HLA-B27 [Presence]

289

2640

1.09

0.79

1.1

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.79

0.0

1.1

—

1843.75

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.79

0.0

2.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

319

2929

1.09

0.78

1.2

3.46

6.21

u/ml

0.62

316

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.66

0.78

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

473

0.78

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

233

1.33

0.78

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

758

0.83

0.77

1.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

510

1.21

0.76

1.8

1.7

2782.17

48658.18

u/ml

1.28

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

108

934

1.15

0.76

1.2

9.43

9.62

mmol/l

0.16

101

874

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

322

2964

1.09

0.75

1.2

9.70

6.40

u/ml

0.33

474

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

647

0.82

0.75

1.1

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

161

0.62

0.75

1.1

1.0

12.17

9.13

mg/g

—

152

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

109

944

1.15

0.75

4.8

5.2

91.78

78.02

u/ml

0.07

289

(3022475) Manganese [Moles/volume] in Blood

1.69

0.75

1.2

1.4

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.69

0.75

1.0

—

(3025130) Human papilloma virus identified in Specimen

612

1.19

0.75

1.6

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

220

0.68

0.74

1.0

1.2

48.50

49.92

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

1.51

0.74

1.1

1.29

1.05

u/field

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

380

0.76

0.74

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

379

0.76

0.73

1.1

—

(40768441) Liver Pathology biopsy report

113

984

1.15

0.73

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.66

0.71

1.2

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

771

0.84

0.70

1.6

1.8

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

273

2506

1.09

0.70

1.2

9.11

5.98

u/ml

0.17

201

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

376

0.77

0.70

1.0

1.1

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.66

0.68

1.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

292

1.26

0.68

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

122

1076

1.13

0.67

1.3

1.4

1.49

1.30

promille

0.68

830

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

373

0.78

0.67

1.0

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.54

0.66

1.0

1.1

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.52

0.66

1.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

1.49

0.66

1.4

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.59

0.65

1.1

1.0

—

(40768800) Prostate Pathology biopsy report

502

4730

1.06

0.65

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

166

0.66

0.64

1.4

1.5

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

777

7410

1.05

0.64

1.2

1.3

70.97

58.05

au/ml

0.49

418

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

177

0.68

0.63

1.0

—

(3022621) pH of Urine by Test strip

980

9398

1.04

0.63

3.4

3.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

859

8214

1.05

0.63

2.3

2.4

28.08

24.94

au/ml

0.23

457

(3000764) Benzodiazepines [Presence] in Urine

143

1587

0.90

0.63

1.6

2.0

—

(3027008) Opiates [Presence] in Urine

144

1597

0.90

0.62

1.6

1.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

802

1.15

0.62

2.0

14.83

16.33

nmol/l

1.33

737

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

1.63

0.62

6.9

6.0

438.87

438.49

umol/l

—

(4212803) Bone marrow aspirate examination

164

1.34

0.61

1.0

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

651

0.84

0.61

1.6

2.0

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

651

0.84

0.61

1.6

2.0

—

(3003771) Antithrombin Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

0.60

0.0

1.1

—

77.67

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

139

0.65

0.60

1.2

1.4

—

(3005570) Glucose [Moles/volume] in Urine

164

1485

1.10

0.59

2.0

1.8

—

1.04

—

(3028300) Cannabinoids [Presence] in Urine

145

1600

0.90

0.59

1.6

2.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

321

0.78

0.59

1.1

1.3

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

150

0.66

0.58

1.7

2.6

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.58

0.0

2.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.58

0.0

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

295

3153

0.93

0.58

1.5

1.7

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.56

0.58

1.2

1.3

1.44

1.27

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

173

0.69

0.58

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

173

0.69

0.58

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

657

0.85

0.57

1.6

2.0

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

310

2892

1.07

0.57

1.3

1.5

0.98

0.83

nmol/l

2.31

256

2391

(3036670) Protein [Mass/volume] in Synovial fluid

548

1.17

0.56

1.3

1.2

36.82

40.44

g/l

1.07

284

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

181

1969

0.92

0.56

1.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

482

0.83

0.55

1.1

1.49

5.28

u/ml

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

194

0.72

0.55

2.4

2.1

—

(44813793) Dust mix specific IgE antibody measurement

689

1.14

0.55

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

328

0.79

0.54

1.6

1.5

0.43

0.40

ug/l

0.17

201

(40768446) Kidney Pathology biopsy report

550

1.16

0.54

1.7

1.6

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.58

0.54

1.0

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

524

0.84

0.54

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

142

1.34

0.53

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

327

0.79

0.53

1.0

0.38

0.70

u/ml

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.41

0.53

1.0

—

(3032057) Clostridioides difficile [Presence] in Stool

370

0.81

0.52

1.3

1.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

478

1.17

0.52

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

133

0.67

0.51

1.2

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

133

0.67

0.51

1.4

1.8

17.67

17.58

umol/l

—

133

(3005033) Fetal Nuchal fold Thickness US

133

0.67

0.51

1.2

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

806

1.13

0.51

2.5

2.4

—

(3006270) Folate [Moles/volume] in Blood

140

1271

1.10

0.51

1.2

318.78

334.68

nmol/l

0.41

106

998

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

387

1.19

0.51

1.2

124.19

131.52

nmol/l

0.15

285

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

146

1593

0.91

0.50

2.9

3.6

23.24

40.24

u/ml

3.15

140

1544

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

188

1.27

0.50

1.2

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

425

1.17

0.49

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

764

0.87

0.49

1.8

2.5

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

378

0.82

0.49

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

176

1903

0.92

0.49

1.4

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

279

0.79

0.49

1.1

1.3

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

1.43

0.48

2.3

3.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

179

1931

0.92

0.48

1.4

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.52

0.48

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

222

0.76

0.47

1.3

1.2

—

(3036180) Methadone [Presence] in Urine

271

1.22

0.47

1.3

2.3

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

188

0.74

0.47

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

125

1136

1.10

0.46

1.1

5.88

3.81

u/ml

0.31

390

(3005988) Vibrio sp identified in Specimen by Organism specific culture

177

1906

0.93

0.46

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

172

1854

0.92

0.46

3.3

4.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

178

1916

0.93

0.46

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

272

1.21

0.46

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.61

0.45

1.0

1.2

212.80

354.79

umol/24h

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

587

0.87

0.44

1.2

55.82

59.46

0.12

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

356

1.18

0.44

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

356

1.18

0.44

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

356

1.18

0.44

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

356

1.18

0.44

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

383

0.83

0.44

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

177

1900

0.93

0.43

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

638

1.13

0.43

1.2

1.5

0.16

0.19

nmol/l

0.50

466

(3016879) Cocaine [Presence] in Urine

138

1495

0.92

0.43

1.6

2.1

—

(3019150) Specific gravity of Urine by Refractometry

3025

29714

1.02

0.42

4.6

4.4

1.02

kg/l

0.88

406

4642

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

1.41

0.42

3.2

2.2

—

(3000034) Microalbumin [Mass/volume] in Urine

138

1494

0.92

0.42

3.1

3.0

50.18

46.00

mg/l

0.11

1093

(3050129) First trimester maternal screen panel - Serum or Plasma

173

0.75

0.42

1.6

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.65

0.42

5.2

5.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

488

0.86

0.42

1.1

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.56

0.42

1.0

1.1

7.69

8.53

mmol/l

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

555

1.13

0.41

1.7

1.5

18.59

9.09

ug/l

0.77

508

(43055514) Macroprolactin [Presence] in Serum or Plasma

131

1.29

0.41

1.5

1.4

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.5

—

126.80

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.41

0.0

1.1

—

0.19

—

(3007542) Rye IgE Ab [Units/volume] in Serum

1.51

0.41

1.0

1.1

—

0.15

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.41

0.0

1.0

—

(3035060) Mercury [Moles/volume] in Blood

0.00

0.41

0.0

2.2

—

18.29

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.35

0.40

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

193

0.78

0.39

2.4

2.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.43

0.39

1.0

1.1

4.20

2.60

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.39

0.0

1.0

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

842

0.90

0.39

1.3

1.36

1.17

nmol/l

0.91

640

(3004616) Nuclear Ab [Presence] in Serum

149

1599

0.93

0.38

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

692

1.11

0.38

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

133

1.28

0.38

1.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

151

1402

1.08

0.37

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

151

1402

1.08

0.37

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

151

1402

1.08

0.37

1.5

1.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.32

0.37

11.1

8.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

224

0.80

0.37

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

107

1.31

0.36

3.7

4.6

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

456

4375

1.04

0.36

3.0

4.0

101.32

82.03

u/ml

0.25

440

4191

(3051101) Glucose [Moles/volume] in Cord blood

331

0.84

0.36

5.6

6.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.46

0.36

1.0

1.1

—

mmol/l

—

(3006462) Nitrate [Presence] in Urine

724

1.10

0.35

3.9

3.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

352

0.85

0.35

1.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.62

0.35

1.0

1.1

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

208

1.20

0.34

1.0

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

774

1.10

0.34

1.0

1.1

7.88

7.12

nmol/l

0.05

173

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

232

0.82

0.34

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

153

1429

1.07

0.33

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

188

0.80

0.33

1.0

1.1

0.56

0.54

u/ml

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.34

0.33

3.3

2.2

16.36

19.24

mg/l

0.40

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

804

1.09

0.33

3.2

3.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

117

1257

0.93

0.33

1.4

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

257

2443

1.05

0.32

1.9

24.02

23.79

ug/l

0.02

250

2386

(3027944) Amphetamines [Presence] in Urine

146

1553

0.94

0.32

1.6

2.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

155

1.22

0.31

1.7

1.8

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

798

1.09

0.31

2.4

0.18

0.25

e9/l

3.07

706

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

220

1.18

0.31

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

304

1.15

0.31

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

988

9643

1.02

0.29

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

366

0.87

0.29

1.4

1.2

0.31

0.32

g/l

0.25

290

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

457

1.11

0.29

1.2

—

(3024869) Neuronal Ab [Presence] in Serum

306

1.14

0.29

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

648

0.91

0.28

1.0

0.05

0.47

u/ml

1.17

211

(3038177) Helicobacter pylori Ab [Presence] in Serum

182

1722

1.05

0.28

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

602

1.09

0.27

1.2

1.4

1.42

1.53

g/l

3.49

602

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

823

1.08

0.27

1.4

1.6

0.94

0.93

g/l

0.13

816

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

727

1.08

0.27

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

405

0.89

0.27

1.3

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

820

0.92

0.26

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

820

0.92

0.26

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

351

0.88

0.25

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

244

1.14

0.25

1.0

1.1

—

(3048879) Bone marrow aspiration report

547

0.91

0.24

1.4

1.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.26

0.24

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.28

0.22

1.2

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.25

0.22

1.0

—

(40760409) HLA-A [Type] by High resolution

1.25

0.22

1.0

—

(40763590) HLA-DQ beta [Type]

1.25

0.22

1.0

—

(40760410) HLA-B [Type] by High resolution

1.25

0.22

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.25

0.22

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

156

0.83

0.21

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

156

0.83

0.21

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

156

0.83

0.21

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

156

0.83

0.21

1.5

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

834

1.06

0.21

2.3

2.4

395.24

533.73

e6/l

1.72

707

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.19

0.21

1.0

1.3

—

(3013862) HLA-DP [Type]

1.19

0.21

1.0

—

(3028433) Virus identified in Specimen by Culture

496

1.09

0.21

1.1

1.2

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

134

0.82

0.21

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

135

1.18

0.21

1.3

11.51

10.06

mmol/l

1.30

129

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

830

0.94

0.20

1.5

1.9

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

963

0.94

0.20

1.0

0.54

1.14

u/ml

0.92

485

(40765096) Chromosome analysis panel by Banding

488

1.08

0.20

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.20

0.0

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.20

0.0

1.2

—

(3001019) Free T4 and TSH panel - Serum or Plasma

308

2981

1.03

0.20

1.5

1.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

817

1.06

0.20

2.9

2.7

32.55

36.84

1.16

448

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

829

0.94

0.20

1.5

1.9

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

281

0.89

0.20

2.7

4.8

116.36

65.92

u/l

0.34

272

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

117

1110

1.05

0.19

1.6

2.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

136

1.17

0.19

1.7

—

(40758358) Immune stain study

1.17

0.19

1.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

212

1.13

0.19

1.0

1.2

44.94

43.90

mg/l

0.04

181

(3026389) Candida sp identified in Specimen by Organism specific culture

188

1807

1.04

0.18

1.3

1.4

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

1.13

0.18

1.7

4.30

1.86

mg/l

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

109

1.19

0.18

1.0

1.1

9.85

9.00

u/l

0.13

109

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

393

0.91

0.18

1.1

1.2

36.78

25.30

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

237

0.88

0.18

1.0

1.5

2.25

2.06

ug/l

—

129

(3047007) Chlamydophila sp Ab [Presence] in Serum

144

1378

1.04

0.18

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

679

0.94

0.17

4.3

5.5

40.33

5606.21

u/ml

—

122

(3045424) Erythrocytes [Presence] in Urine

235

2415

0.97

0.16

1.4

1.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

118

1228

0.96

0.16

1.6

2.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

601

1.06

0.16

1.1

—

(4034850) Laboratory test

462

4517

1.02

0.16

16.1

11.4

—

(3052592) Norovirus Ag [Presence] in Stool

338

0.91

0.15

1.3

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

119

0.84

0.15

1.1

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

0.78

0.15

11.5

165.83

192.13

e6/l

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.78

0.15

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.79

0.14

1.0

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

694

6823

1.02

0.14

2.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

125

1293

0.96

0.14

1.1

0.89

1.41

u/ml

0.66

663

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

263

0.91

0.13

1.5

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

193

1980

0.97

0.13

1.1

5.34

585.06

iu/ml

1.03

388

(3022689) Creatine [Moles/volume] in Urine

441

1.06

0.13

1.3

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

151

1.12

0.13

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

344

1.07

0.12

1.4

1.6

9.83

9.48

ug/l

0.14

344

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

127

0.86

0.12

1.0

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

579

0.95

0.12

1.0

1.1

10.68

10.71

iu/ml

—

129

(3017315) Amylase [Enzymatic activity/volume] in Urine

817

1.04

0.10

1.2

247.35

387.27

u/l

1.26

757

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

143

1389

1.03

0.10

1.2

7.83

7.82

mmol/l

0.00

123

1163

(3045683) HLA typing for celiac disease panel - Blood or Tissue

475

1.05

0.10

1.0

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

134

1371

0.97

0.09

1.2

1.3

1.60

1.41

nmol/l

1.21

121

1237

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

310

1.06

0.09

1.1

1.2

0.75

50.85

mg/l

1.26

242

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

1.15

0.09

1.0

1.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

144

0.90

0.08

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

154

0.91

0.08

1.3

2.2

2.92

10.71

ug/l

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

164

0.91

0.08

1.3

—

(40762814) Titanium [Mass/volume] in Blood

347

0.95

0.08

2.3

2.2

3.00

3.44

ug/l

0.58

121

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.85

0.07

1.0

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.81

0.07

1.2

1.5

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.12

0.07

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

346

0.95

0.07

1.1

1.39

1.02

u/ml

0.15

119

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1.07

0.07

1.3

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

142

1389

1.02

0.07

1.6

1.9

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.86

0.06

1.1

1.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

0.84

0.06

1.1

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

100

0.90

0.06

3.2

3.0

—

(40758292) HTLV I+II Ab panel - Serum

192

0.94

0.06

1.2

1.4

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

799

1.02

0.05

1.0

1.58

2.86

u/ml

1.17

372

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

151

0.92

0.05

5.4

5.5

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

151

0.92

0.05

7.0

9.3

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

594

0.97

0.04

2.2

2.3

53.34

54.84

umol/l

0.12

494

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

110

1.09

0.04

1.4

1.8

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

150

0.93

0.04

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

317

1.04

0.04

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

109

1105

0.98

0.04

1.3

1.4

165.54

172.46

pmol/l

0.24

109

1105

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

210

0.95

0.04

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

139

0.93

0.04

1.2

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

634

6294

1.01

0.04

1.9

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

112

1132

0.99

0.03

1.3

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

313

3142

0.99

0.03

1.8

1.7

—

(3027035) Albumin [Mass/time] in 24 hour Urine

151

1.06

0.03

1.3

909.22

287.53

mg/24h

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

151

1.06

0.03

1.3

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

271

2722

0.99

0.03

1.2

1.1

9.81

11.04

u/ml

0.14

222

(3008401) Mugwort IgE Ab [Units/volume] in Serum

108

1091

0.99

0.03

1.0

1.1

0.41

1.12

u/ml

1.88

449

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

171

1.05

0.03

1.0

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

321

3184

1.01

0.02

1.4

1.3

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

168

0.95

0.02

1.4

1.7

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

110

1110

0.99

0.02

1.3

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

248

0.97

0.02

1.2

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

210

2081

1.01

0.02

2.6

2.1

32.34

27.10

mg/l

0.64

546

(3025018) Bordetella pertussis Ab [Titer] in Serum

498

0.98

0.02

1.1

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

167

0.96

0.02

1.8

2.9

—

(3023511) Choriogonadotropin [Units/volume] in Urine

197

0.96

0.02

1.6

1.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.07

0.01

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

362

3598

1.00

0.01

2.9

3.2

780.76

902.83

u/ml

0.12

321

3279

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

183

1.04

0.01

2.6

2.8

0.53

0.43

u/field

0.19

183

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

188

1867

1.00

0.01

1.3

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

112

1124

0.99

0.00

1.0

1.1

1.76

3.31

u/ml

1.01

523

(3023430) Cat dander IgE Ab [Units/volume] in Serum

742

1.01

0.00

1.0

0.41

2.99

u/ml

5.85

292

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

134

1.04

0.00

1.1

1.9

0.58

1.16

mmol/l

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

128

1271

1.00

0.00

2.1

2.2

1.30

2.13

u/field

1.42

482

(3014271) Vancomycin [Susceptibility]

103

1033

0.99

0.00

3.2

3.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

150

1.00

0.00

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

171

0.99

0.00

1.4

1.7

57.00

44.50

umol/l

0.55

171

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

164

0.97

0.00

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

164

0.97

0.00

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

121

0.99

0.00

1.1

2.38

3.38

u/ml

0.12

(3009015) Lactate [Moles/volume] in Synovial fluid

191

0.99

0.00

1.2

6.99

6.59

mmol/l

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

117

1.02

0.00

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

110

1.00

0.00

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

127

1.02

0.00

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

152

0.98

0.00

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

195

0.97

0.00

1.3

1.5

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

173

0.98

0.00

1.1

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

103

0.97

0.00

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3011324) Intrinsic factor Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1.01

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.2

—

18.88

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.91

0.00

6.4

6.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.2

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

0.0

2.8

—

3.40

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.1

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.89

-0.00

1.0

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

1.8

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.95

-0.00

1.3

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

6.88

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.0

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.0

—

3.43

—

(3017509) Phencyclidine [Presence] in Urine

0.97

-0.00

1.3

1.5

—

(3002853) Influenza virus B Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CARDIOVERSION – Cardiodefibrillation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Cardiodefibrillation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Cardiodefibrillation (CARDIOVERSION)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints